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Somatic symptoms are a significant medical and mental health concern that 
affects healthy adults and places a significant burden on healthcare systems. The 
perseverative cognition hypothesis posits that perseverative cognition results in 
prolonged physiological activation that may be interpreted as somatic symptoms. The 
purpose of this study was to further examine this hypothesis in a sample of young adults. 
First, I hypothesized that perseverative cognition would prospectively predict somatic 
symptoms after controlling for anxiety and depression. Second, I hypothesized that 
parasympathetic nervous system functioning, measured as respiratory sinus arrhythmia 
(RSA) and sympathetic nervous system functioning, measured as electrodermal 
responding (EDR) would mediate this relationship. RSA and EDR were measured before, 
during, and after a stressor task to provide measures of basal levels, reactivity to the 
stressor, and recovery from the stressor respectively. 
These hypotheses were tested in a sample of 220 young adults. Participants 
ranged from 18 to 39 years old (M = 19.63, SD = 12.10), 84.5% of the participants were 
female, and 65.5% were Caucasian. Perseverative cognition predicted somatic symptoms 
in the unexpected direction in both hypothesized models (RSA: β = -0.23, p = 0.001; 
EDR: β = -0.23, p = 0.074). When anxiety and depression were removed as covariates, 
somatic symptoms were significantly predicted by perseverative cognition in the 
expected direction in both models (RSA: β = 0.38, p < 0.001; EDR: β = 0.37, p = 0.003). 
Neither RSA nor EDR at any time point were significantly related to either perseverative 
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cognition or somatic symptoms, and no indirect effects were observed. Individual 
mediations revealed that RSA recovery significantly predicted somatic symptoms (β = 
0.16; p = 0.029) such that individuals whose parasympathetic nervous system re-engaged 
following the stressor experienced a higher level of somatic symptoms. Additionally, 
individuals who reported higher levels of perseverative cognition experienced greater 
increases in EDR during the stressor task (β = 0.17; p = 0.041). Overall, the findings of 
this study suggest that perseverative cognition is related to sympathetic nervous system 
functioning, while parasympathetic nervous system functioning is related to reporting of 
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CHAPTER I 
Introduction and Literature Review 
Purpose    
 Somatic symptoms are a significant medical and mental health concern that affect 
American adults. Somatization has been defined as “a tendency to experience and 
communicate somatic distress in response to psychosocial stress and to seek medical help 
for it,” (Lipowski, 1988). Somatization may manifest in a number of symptoms, such as 
back pain, indigestion, and fatigue.  A number of epidemiological studies have revealed 
that even healthy adults report more than one somatic symptom each week (Nimnuan, 
Hotopf, & Wessely, 2001). However, there are also individuals who report and seek 
medical attention for multiple somatic symptoms, and these individuals may have health 
care costs that are up to nine times that of the average primary care patient (Smith, 
Monson, & Ray, 1986). Thus, somatic symptoms place a significant burden on health 
care systems, accounting for an estimated one-third of all medical visits (Kroenke & 
Price, 1993; Kroenke et al., 1994)  
 Many of the current theories of somatization have drawn from the theoretical 
basis for hypochondriasis (Barsky & Wyshak, 1990; Kirmayer & Taillefer, 1997) and 
focus on worry about one’s health as a key factor in the development and maintenance of 
somatic symptoms. These cognitive-perceptual models focus on a vicious cycle in which 
normal somatic perception is amplified, resulting in a physical interpretation of 
psychological distress. Some of these models also take into account the social and 
behavioral contexts that reward and maintain the help-seeking behaviors associated with 
somatic symptoms (Deary, Chalder, & Sharpe, 2007; Kirmayer & Taillefer, 1997). 
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More recently, both Brown (2004) and more directly Brosschot, Gerin, and 
Thayer (2006) have broadened this focus on worry about physical symptoms as a 
perpetuating factor in somatic symptoms to include all perseverative cognition (e.g. 
worry and rumination). Brosschot, Gerin, and Thayer (2006) posit that the key 
component in the development of somatic symptoms is not the act of worrying about 
health specifically, but the perseverative nature of these thoughts that result in prolonged 
physiological activation that may be interpreted as somatic symptoms. Thus, it may be 
that perseverative cognition results in somatic symptoms through the mechanism of 
prolonged physiological activation. 
The purpose of the current study is to further examine the perseverative cognition 
hypothesis proposed by Brosschot, Gerin, and Thayer (2006) in a sample of young adults. 
First, I hypothesized that perseverative cognition would prospectively predict somatic 
symptoms. Second, I hypothesized that physiological activation would mediate this 
relationship. Specifically I examined the mediating role of respiratory sinus arrhythmia 
(RSA) and electrodermal responding (EDR) in response to induced stress.  In the below 
sections I review the historical and theoretical underpinnings of somatic symptoms, as 
well as contemporary integrative models of somatic symptoms. I then discuss the 
theoretical and empirical basis for the hypothesized relationship between perseverative 
cognition and somatic symptoms. Finally, I discuss RSA and EDR as potential mediators 
of this relationship. 
Conceptualization of Somatic Symptoms 
 Though earlier definitions of somatization have focused on medically unexplained 
symptoms (American Psychiatric Association, 2000), the DSM-5 considers somatic 
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symptoms to be physical manifestations of psychological distress that may or may not be 
associated with a medical condition (American Psychiatric Association, 2013). Current 
diagnostic criteria for Somatic Symptom Disorder are (a) one or more somatic symptoms 
that are distressing and/or result in a significant disruption in daily life; (b) excessive 
thoughts, feelings, and/or behaviors related to these somatic symptoms or associated 
health concerns; and (c) the state of being symptomatic persists for at least six months 
(although any one symptom may not be continuously present). As Somatic Symptom 
Disorder is a new diagnosis, its prevalence is unknown to date. However, according to 
the DSM-5 (American Psychiatric Association, 2013), it is likely that the prevalence will 
be higher than that of the more restrictive DSM-IV diagnosis of somatization disorder, 
which had a prevalence rate of less than 1%. Similarly, the prevalence of this disorder 
will likely be lower than that of undifferentiated somatoform disorder, which had a 
prevalence rate of 19%. Thus the prevalence of somatic symptoms disorder in the general 
population has been estimated to be approximately 5-7%. Additionally, gender 
differences in somatic symptom disorder have not yet be studied because of the novelty 
of this diagnosis. It has previously been demonstrated that women tend to report higher 
levels of somatic symptoms, so it is likely that the prevalence of somatic symptom 
disorder will also be higher in females. Additional risk factors for somatic symptom 
disorder may include trait negative affectivity, low levels of education, low 
socioeconomic status, and the experience of recent stressful life events (American 
Psychiatric Association, 2013).  
Somatic symptoms such as back pain, indigestion, and fatigue are common and 
associated with distress and impairment even in sub-clinical populations. In an 
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epidemiological study of somatization, Hiller, Reif, and Brahler (2006) found that 81.6% 
of a representative German sample reported at least one symptom causing at least mild 
impairment and 22.1% reported at least one symptom causing severe impairment. This 
corroborates the findings of other research on the prevalence and severity of somatic 
symptoms in non-clinical populations (Janca, Isaac, & Ventouras, 2006; Rief, Hiller, & 
Margraf, 1998). In primary care settings, somatic symptoms account for a quarter to half 
of all patient visits, suggesting impairment (Barsky, 1995; Court, 1995). Patients with 
somatic symptoms utilize greater than average amounts of health care services, resulting 
in substantial direct and indirect costs (Konnopka et al., 2013). 
Theoretical Framework of Somatic Symptoms 
 Introduction.  Psychologists and medical practitioners have recognized somatic 
symptoms throughout history. The earliest systematic account of somatic symptoms was 
dissociation theory as developed by Janet (1889, 1907) which was later extended into the 
concept of conversion (Strachey et al., 1955). More recently, however, contemporary 
theories have turned their attention to cognitive-behavioral factors that result in 
somatization (Barsky & Wyshak, 1990; Brosschot et al., 2006; Brown, 2004; Kirmayer & 
Taillefer, 1997).  In the following sections I will first review early theoretical 
understandings of somatic symptoms. Next, I will provide an overview of current 
integrative models of somatic symptoms. Finally, I will describe the perseverative 
cognition hypothesis (Brosschot et al., 2006) a portion of which my dissertation will 
examine. 
 Early theories of somatic symptoms.  Psychologists and medical practitioners 
have recognized somatic symptoms throughout history. One of the most well-know and 
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accepted understandings of dissociation is Freud’s theory of conversion. Conversion 
theory posits that somatic symptoms are a defense against negative emotions activated 
when the brain attempts to regulate negative affect through suppression of traumatic 
memories. Though suppression initially protects the individual from overwhelming 
negative affect, the neural energy associated with this negative affect is not appropriately 
released, and instead “converted” into somatic symptoms. Thus, an individual can 
express psychological distress by developing somatic symptoms without conscious 
awareness of the negative affect, reducing anxiety. Freud also noted that conversion also 
allowed for secondary gains, such as attention and avoidance of work (Roelofs & 
Spinhoven, 2007; Strachey et al., 1955). 
Though this model has been widely accepted in much of the medical practice, 
there have not been any systematic studies of conversion, and this model does not seem 
to adequately account for the findings of the current literature on somatic symptoms 
(Roelofs & Spinhoven, 2007). Two studies have raised the possibility that somatic 
symptoms may resolve the experience of negative affect, but their validity has been 
called into question (Bishop Jr. & Torch, 1979; Raskin, Talbott, & Meyerson, 1966; 
Roelofs & Spinhoven, 2007). Additionally, if this were the case, we would expect to find 
lower levels of negative affect and psychological distress among individuals with high 
levels of somatic symptoms; in fact, several studies have indicated that the opposite is 
true – somatic symptoms are associated with elevated levels of distress (Kroenke, 2003; 
Simon, VonKorff, Piccinelli, Fullerton, & Ormel, 1999).  
Though Freud’s model may be the most well-known early theory of somatic 
symptoms, the earliest systematic account of somatic symptoms was dissociation theory 
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as developed by Janet (1889, 1907). Janet considered dissociation to be a state in which 
mental operations that are normally integrated with other mental functions operate 
outside the sphere of conscious awareness and memory. This definition of dissociation 
was based on his observations of individuals with “hysteria,” a broad class of 
psychopathologies including dissociative disorders, conversion disorders, somatic 
symptom disorders, borderline personality disorder, and post-traumatic stress disorder. At 
the time, it had already been established that hysteria often followed stressful life events. 
Thus, Janus’ understanding of dissociation focused on the role of dissociation in 
traumatically induced disorders (Roelofs & Spinhoven, 2007). 
Janus posited that when individuals experience a traumatic event, they also 
experience a spontaneous narrowing of attention resulting in the development of somatic 
symptoms through two mechanisms. First, the spontaneous attentional narrowing limits 
the number of sensory channels that can be attended to simultaneously, resulting in a loss 
of deliberate attentional control over channels that are not attended to. Over time, this 
attention style may become a habitual pattern, and though information is processed by the 
unattended to channel, this occurs outside of conscious awareness. This dissociated 
information processing results in negative dissociation symptoms, including memory 
loss, loss of motor control, and loss of somatosensory awareness. Second, according to 
Janus, attentional narrowing makes it unlikely that the individual will have full awareness 
of the traumatic event, preventing the integration of new memories into the individuals’ 
existing personal knowledge and sense of identity. Thus, individuals have little control 
over the activation of these memories resulting in positive dissociation symptoms, 
including re-experiencing, sensory distortions, and pain (Roelofs & Spinhoven, 2007).  
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Though there is strong empirical evidence to suggest that traumatic experiences 
may induce dissociative experiences, few studies have examined this relationship among 
individuals with somatic symptoms (Gershuny & Thayer, 1999; Roelofs & Spinhoven, 
2007). There is research that suggests that there tends to be correlation between 
dissociative experiences and somatic symptoms (R. J. Brown, Schrag, & Trimble, 2005; 
Nijenhuis, Spinhoven, van Dyck, van der Hart, & Vanderlinden, 1998) but few studies 
have examined dissociation as an explanatory factor in the relationship between trauma 
and somatic symptoms (Roelofs & Spinhoven, 2007). In fact, Pribor, Yutzy, Dean, and 
Wetzel (1993) found that the relationship between dissociation and somatic symptoms 
disappeared after controlling for trauma.  Thus, it seems that trauma, rather than the 
tendency toward dissociation that may arise from it, is a more important vulnerability 
with regard to the development of somatic symptoms. 
There are a number of studies that have found that a history of trauma such as 
childhood physical or sexual abuse is a risk factor for somatic symptoms (Fiddler, 
Jackson, Kapur, Wells, & Creed, 2004; Kimerling & Calhoun, 1994; Kugler, Bloom, 
Kaercher, Truax, & Storch, 2012; Morrison, 1989; Petkus, Gum, King-Kallimanis, & 
Wetherell, 2009; Sack, Lahmann, Jaeger, & Henningsen, 2007; Stein et al., 2004). In a 
review of this literature, Roelofs & Spinhoven  (2007) concluded that in subgroups of 
individuals with clinical levels of somatic symptoms, there are significantly greater levels 
of abuse. However, all of these studies are retrospective in nature, making it difficult to 
draw any conclusions about causality. Despite this limitation, it will be important to 
control for the effect of trauma history on somatic symptoms in order to disentangle the 
relationship of more proximal variables to the development and maintenance of somatic 
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symptoms. 
Integrative models of somatic symptoms.  While nearly all theories of somatic 
symptoms suggest that they represent emotional distress experienced and expressed as 
physical symptoms, contemporary theories have examined the mechanisms by which 
individuals may translate stress or emotional distress into physical symptoms.  Barsky & 
Wyshak (1990) developed one of the earliest integrative models of somatic symptoms, 
and it has since been quite influential. Their model was first applied to hypochondriasis, 
and focuses on cognition and perception as a key mechanism. Similar to models of panic 
and depression, they note that individuals who are prone to hypochondriasis and somatic 
symptoms amplify normal or benign physical sensations and believe that they are 
indicative of serious disease. Because the patient is anxious about the possibility of 
having a serious disease, he or she begins to focus additional attention on his or her own 
bodily processes and sensations. The individual then begins to experience a broad range 
of more intense, bothersome, and concerning physical sensations, resulting in a higher 
level of anxiety and additional focus on physical sensations, and ultimately leading to a 
vicious circle. This process has since been described as somatosensory amplification. 
Though this theory has been influential in the literature, it is problematic in that it is a 
model developed for hypochondriasis and applied to somatic symptoms. Though there is 
clearly a conceptual connection between these two symptom profiles, only a small 
portion of patients diagnosed with somatization syndrome also qualify for a diagnosis of 
hypochondriasis (Rief et al., 1998). Additionally, this model fails to account for external 
factors that may perpetuate somatic symptoms. 
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Barsky and Wyshak’s (1990) model was later extended by Kirmayer and Taillefer 
(1997) to encompass social and forensic factors in addition to cognitive and perceptual 
factors. They posited that, initially, physical symptoms might be due to a known medical 
problem or normal bodily sensations that are a part of daily living. The amount of 
attention that is focused on the body will result in varying degrees of awareness of these 
physical sensations. Once specific bodily sensations enter into awareness, the individual 
evaluates their relative importance. In individuals prone to somatic symptoms, the 
importance of benign physical sensations are often amplified through attribution to 
illness, cognitive distortions, and vulnerability schemas based on past illness experiences. 
These cognitive and emotional reactions to physical sensations prompt illness behaviors 
such as seeking help and reassurance, often from medical professionals or within the 
individual’s own social context. These interpersonal interactions may have the effect of 
reinforcing these patterns, or promoting recovery. Amplification and maladaptive 
attributions of physical symptoms may also result in avoidance behaviors in both social 
and occupational contexts, resulting in functional limitations and physical 
deconditioning. The various psychological and social mechanisms may increase 
physiological reactivity.  
Deary, Chalder, and Sharpe (2007) proposed a similar mode of somatic symptoms 
that places these factors within the cognitive-behavioral framework of predisposing, 
precipitating, and perpetuating factors. The fundamental assumption of this model is that 
somatic symptoms are maintained by cognitive, behavioral, and physiological factors that 
are part of an autopoietic cycle. A genetic vulnerability to somatic symptoms combined 
with childhood trauma serve as predisposing factors, increasing the likelihood that an 
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individual will develop somatic symptoms. Stressful life events lead to physiological 
symptoms of stress, producing somatic symptoms and beginning the process of selective 
attention and sensitization. The individual then associates stress with somatic symptoms 
and, through operant conditioning processes of avoidance, begins to avoid activities that 
may lead to additional symptoms. This becomes a vicious cycle of ever-increasing 
symptomology. 
Brown (2004) proposed an integrative conceptual model of medically 
unexplained symptoms. Brown notes that somatic symptoms can be explained by 
research and theory from cognitive psychology, and focuses on the nature of attention 
mechanisms in the cognitive system. An individual’s cognitive system is constantly 
inundated with information that may influence his or her thoughts and behaviors. 
According to the hierarchical cognitive model of attentional control proposed by Norman 
and Shallice (1986), one of the primary tasks of the attention system is to filter this 
information to determine what requires further processing. The parallel spread of 
activation within these systems results in the generation of multiple perceptual 
hypotheses, each of which provides an interpretation of the world based on current 
perceptions and previous experiences. The “Primary Attentional System” (PAS), which is 
characterized by intuitive, effortless, and self-evident operation, then selects the most 
active perceptual hypothesis. The individual then uses this hypothesis to organize 
relevant information into “primary representations” that provide an understanding of the 
environment and guides future actions.  In contrast, the counterpart of the PAS, the 
“Secondary Attention System” (SAS), is characterized by effortful and deliberate 
operation, and is associated with self-awareness. This understanding of the cognitive 
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system, however, underscores the fact that oftentimes behavior is at least partially 
determined by the PAS, a system that operates without purposeful control. Thus, on some 
occasions, there may not be a direct relationship between sensory stimulation and 
personal experience, and often the generation of perceptual experience can be over-
determined by past experience. 
According to Brown’s (2004) theory, medically unexplained symptoms arise 
when the PAS selects “rogue representations,” which is a general term for information 
that is inappropriately selected by the PAS. Rogue representations may arise from many 
sources within the cognitive system, including memories of organic pathology, exposure 
to physical symptoms in others, sociocultural transmission, and verbal suggestion. The 
rogue representation selected by the PAS results in activation of the SAS such that the 
individual begins paying selective attention to physical sensations, disease-confirming 
information and negative affect, resulting in repeated activation of the rogue 
representation within the cognitive system. These secondary attention processes facilitate 
reactivation of the rogue representation in the memory system 
The perseverative cognition hypothesis. Though previous theories have taken 
into account the role of worry about health conditions as an important factor in the 
development and maintenance of somatic symptoms, these theories have focused on the 
content rather than the nature of these cognitions. Additionally, current theories do not 
propose a clear mechanism for the relationship between cognitions and somatic 
symptoms. Brosschot and colleagues (2006) propose that it is not the health-related 
content of thoughts that result in the development of somatic symptoms, but rather the 
repetitive nature of these thoughts, which they term “perseverative cognition.”  
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Perseverative cognition has been defined as “the repeated or chronic activation of the 
cognitive representation of one or more psychological stressors,” (Brosschot et al., 2006). 
Additionally, they posit that perseverative cognition plays a much broader role in 
psychopathology, and is likely a crucial factor in somatic health as well. Specifically, 
they have proposed that perseverative cognition prolongs physiological activation in 
response to a stressor. This prolonged physiological activation is the mechanism through 
which they believe that perseverative cognition impacts somatic health (Figure 1). 
However, no studies have directly examined this explanatory pathway. 
Perseverative Cognition 
As noted above, perseverative cognition has been defined as “the repeated or 
chronic activation of the cognitive representation of one or more psychological stressors,” 
(Brosschot et al., 2006). A number of cognitive processes such as anticipatory stress, 
cognitive intrusions, obsessions, and craving have a common feature in that they are 
repetitive. However, the two most well studied types of perseverative cognition are worry 
and rumination.  
Worry. Worry has been defined as an uncontrollable chain of fear-laden thoughts 
and images that plays a role in nearly all anxiety disorders (Borkovec & Ray, 1998; 
Borkovec, Robinson, Pruzinsky, & DePree, 1983). Generally, when an individual 
experiences worry, they engage in self-talk about negative events he or she is afraid may 
happen in the future. Eysenck and Calvo (1992) presented a cognitive model of worry, 
which posits that it has three major functions: alarm, prompt, and preparation. Initially, 
worry serves as an alarm, where upon initial detection of an internal or external threat, 
information about the threat is brought into awareness. Second, threat-related thoughts 
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and images from long-term memory are then prompted into conscious awareness. The 
preparation function finally permits the individual to anticipate negative future scenarios 
and initiate anticipatory coping, which may include trying to prevent the anticipated 
negative developments or to prepare for the expected negative event or outcome. 
Oftentimes, individuals feel as though the reason they worry is because it helps them to 
discover ways to avoid negative future events, or prepares them for negative events if 
they are unavoidable (Borkovec & Roemer, 1995; G. C. L. Davey, Tallis, & Capuzzo, 
1996; Freeston, Rheaume, Letarte, Dugas, & Ladouceur, 1994). It has also been theorized 
that worry may serve to suppress somatic anxiety or distract the worrier from more 
emotionally laden topics (Borkovec & Ray, 1998). 
Though worry may subjectively seem to be a productive mental task, empirical 
research has linked worry to a number of disorders and negative outcomes. Worry is a 
cardinal feature of Generalized Anxiety Disorder according to the DSM-5 (American 
Psychiatric Association, 2013) and is also a common process in other psychological 
disorders, including panic disorder, social anxiety disorder, obsessive-compulsive 
disorder, post-traumatic stress disorder, and anorexia nervosa (Papageorgiou, 2006). For 
example, in a prospective study of the relationship between worry and anxiety and 
depression in undergraduate students, researchers found that worry was associated with 
both depression and anxiety (Segerstrom, Tsao, Alden, & Craske, 2000). 
Worry has also been specifically associated with somatic symptoms (Borkovec, 
1994; Brosschot & van der Doef, 2006; Brosschot, 2002; Freeston et al., 1996; Rector & 
Roger, 1996). Borkovec (1994) found that worry is associated with pain, and Freeston 
and colleagues (1996) found that worry is associated with physical symptoms similar to 
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those found in generalized anxiety disorder. Brosschot and Van Der Doef (2006) found 
that daily worrying was predictive of a broad set of somatic complaints after controlling 
for trait anxiety, sex, and age. Additionally, participants who were instructed to use a 
worry postponement strategy reported fewer somatic complaints than participants who 
were not, and this effect was mediated by worry duration. 
Rumination. Similar to worry, rumination is when an individual experiences 
repetitive, intrusive negative cognitions (Papageorgiou & Siegle, 2003). Though a 
number of definitions have been proposed for rumination, generally ruminative thoughts 
are characterized by conscious cognitive activity, recurrence, uncontrollability, and 
negative content (Thomsen, Yung Mehlsen, Christensen, & Zachariae, 2003). 
Rumination is believed to arise in response to goal discrepancies (Martin & Tesser, 1996) 
or stressful, uncontrollable events (Clark, 1996; King & Pennebaker, 1996; Segerstrom et 
al., 2000). Martin and Tesser (1996) have proposed that the goal of rumination for 
individuals is to reduce discrepancies, though it is not always beneficial or helpful in 
meeting this goal. Nolen-Hoeksema’s (1991) response styles theory suggests that 
rumination helps individuals to turn their attention inward, evaluate a problematic 
situation and their emotions about it, and gain insight. In support of this possibility, an 
experimental study conducted by Lyubomirsky and Nolen-Hoeksema (1993) determined 
that when dysphoric participants underwent a rumination induction, they believed that 
they were gaining insight about themselves and their problems However, the solutions 
they produced were relatively poor. 
Research has demonstrated that there are individual differences in levels of 
rumination, such that some individuals may be more prone to ruminate than others 
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(Martin & Tesser, 1996; McIntosh, Harlow, & Martin, 1995; Susan Nolen-Hoeksema, 
Parker, & Larson, 1994). Higher levels of rumination have been well established as a 
predisposing and perpetuating factor in depression, and has specifically been associated 
with increased severity and length of depressed mood in major depressive disorder 
(Martin & Tesser, 1989; Susan Nolen-Hoeksema, 1987, 1991; Segerstrom et al., 2000; 
Teasdale & Barnard, 1993; Wells & Matthews, 1994). Rumination has also been 
associated with negative outcomes linked to depression including negatively biased 
thinking, difficulties with problem solving, decreased motivation, impaired concentration, 
and increased stress (Lyubomirsky & Tkach, 2008). There is also preliminary evidence to 
suggest that rumination is an important process in the development and maintenance of 
anxiety disorders (Blagden & Craske, 1996; Muris, Roelofs, Rassin, Franken, & Mayer, 
2005; Nolen-Hoeksema, 2000). 
In addition to being associated with depression, and to a lesser extent, anxiety, 
rumination has also been associated with increased levels of somatic symptoms (Lok & 
Bishop, 1999; Rector & Roger, 1996; Thomsen et al., 2004). In a study conducted by 
Rector & Roger (1996) students completed self-report measures of rumination, somatic 
symptoms, and a range of other coping and personality measures just after starting 
college, and then eight weeks later. Thus, data were collected during a presumably 
stressful life period. Rumination was initially associated with somatic symptoms, but the 
correlation was not significant at the eight-week follow-up. In another study, rumination 
was associated with somatic symptoms in Asian adults (Lok & Bishop, 1999). This effect 
was mediated by perceived stress. Neither of these studies controlled for affective 
symptoms, however. More recently, Thomsen (2004) conducted a longitudinal 
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examination of the relationship between rumination and self-reported physical health in 
young and elderly adults. At baseline, rumination significantly predicted somatic 
symptoms, and this relationship was mediated by negative affect. However, in their 
longitudinal analyses, rumination predicted somatic symptoms only among the young. 
The mixed findings across these studies indicate that further research is warranted to 
clarify the relationship between rumination and somatic symptoms. This is one of the few 
studies that have controlled for negative affect in addition to sex, baseline somatic 
symptoms, and life events; however, symptoms of depression and anxiety were not 
included as covariates. 
In sum, the distinction made between worry and rumination is that worry 
corresponds to domains of future threat, while rumination corresponds to domains of past 
loss. Similarly, worry has particularly been associated with anxiety disorders while 
rumination has been associated with depressive disorders. However, there is evidence to 
suggest that much of worry is over past events (Borkovec et al., 1983; Molina, Borkovec, 
Peasley, & Person, 1998). Additionally, depressive rumination may include concern 
about future implications of depressive symptoms (Nolen-Hoeksema, 1991). Elevated 
levels of worry have been associated not only with anxiety symptoms, but also depressive 
symptoms (Starcevic, 1995). Thus, it is likely that the recurrent nature of these thoughts 
is salient in the development of anxiety and depression as proposed by Segerstrom and 
colleagues (2000). Brosschot, Gerin, and Thayer (2006) have extended this possibility to 
include not only outcomes of anxiety and depression, but also somatic symptoms, and 
there is some empirical support for this relationship to date (Brosschot, 2002; Rector & 
Roger, 1996; Borkovec, 1994; Freeston, Dugas, Letarte & Rheaume, 1996; Brosschot & 
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Van Der Doef, 2006; Thomsen et al, 2004; Lok & Bishop, 1999; Rector & Roger, 1996). 
However, it remains to be seen whether perseverative cognition is prospectively related 
to somatic symptoms after controlling for symptoms of depression and anxiety.  
Physiological Activation as a Mediator 
Brosschot, Gerin, and Thayer have also proposed physiological activation as a 
potential mechanism of the relationship between perseverative cognition and somatic 
symptoms. A number of studies have indicated that there is an association between 
perseverative cognition and a variety of cardiovascular and skin conductance measures, 
including heart rate, heart rate variability, skin conductance level, and blood pressure 
(Brosschot, van Dijk, & Thayer, 2003; Dua & King, 1987; Glynn, Christenfeld, & Gerin, 
2002; Lyonfields, Borkovec, & Thayer, 1995; Neumann, Waldstein, Sollers, Thayer, & 
Sorkin, 2001; Roger & Jamieson, 1988; Schwartz, Gerin, Davidson, & Christenfeld, 
2000; S C Segerstrom, Glover, Craske, & Fahey, 1999; Suchday, Carter, Ewart, Larkin, 
& Desiderato, 2004; Thayer, Friedman, & Borkovec, 1996). These measures are all 
examples of psychophysiological markers of autonomic nervous system activity. 
The autonomic nervous system is the portion of the peripheral nervous system 
responsible for the control of bodily functions that are not consciously directed, such as 
heart rate and breathing. The autonomic nervous system consists of both the sympathetic 
nervous system and the parasympathetic nervous system. The sympathetic nervous 
system is activated during the “fight or flight” response, and serves to prepare an 
organism for activity by increasing heart rate, respiration, and blood pressure; in contrast, 
the parasympathetic nervous system opposes these effects by slowing heart rate and 
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respiration, and increasing digestion (often termed “rest and digest; Zisner & Beauchaine, 
2015). 
 Electrodermal responding (EDR). Electrodermal responding (EDR) refers to 
the phasic changes in skin conductance that is measured by capturing current flow across 
the surface of the skin while voltage is held constant in areas of the body with high 
concentrations of eccrine sweat glands. This specific type of sweat gland is primarily 
found on the palms of the hands and the soles of the feet and is innervated by the 
sympathetic nervous system. Research has shown that eccrine sweat glands are more 
reactive to emotion than sweat glands in other parts of the body. Thus, assessing eccrine 
sweat gland activity and reactivity to stimuli provides psychophysiological information 
regarding individual differences in emotional reactivity that is specific to the sympathetic 
nervous system. Specifically, both the number of electrodermal responses and relative 
magnitude of those responses capture sympathetic nervous system orienting and 
reactivity (Zisner & Beauchaine, 2015). 
 Previous research has indicated that EDR is a biomarker for both internalizing and 
externalizing symptoms of psychopathology. For example, individuals with high levels of 
trait anxiety also exhibit greater electrodermal activity when compared to a control group. 
In contrast, individuals with externalizing disorders, low anxiety, or high levels of 
aggression are more likely to exhibit low levels of electrodermal activity (Zisner & 
Beauchaine, 2015). Though the literature on the relationship between EDR and somatic 
symptoms is limited, there is some evidence to suggest an association. For example, 
Kanbara and colleagues (2004) found that individuals with somatic symptoms had a 
lower level of physiological reactivity, including electrodermal activity, than a control 
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group. As somatic symptoms are generally considered an internalizing symptom 
however, this finding is contrary to the literature suggesting that internalizing disorders 
are related to increased electrodermal activity. Thus, additional research is needed in 
order to better understand the relationship between EDR and somatic symptoms. 
Respiratory sinus arrhythmia (RSA). Parasympathetic nervous system activity 
is often measured using vagal tone, which refers to the tonic influence of the vagus nerve 
on the sino-atrial node of the heart (Porges, 1995). Respiratory sinus arrhythmia (RSA), 
an indirect measure of vagal tone, refers to the changes in heart rate across the respiratory 
cycle. The predictable changes in heart rate across the respiratory cycle occur due to 
increases in inhibitory parasympathetic signaling during exhalation, and decreases in 
inhibitory parasympathetic signaling during inhalation.  Previous research has indicated 
that RSA likely serves as an important transdiagnostic biomarker of emotion 
dysregulation difficulties (for a complete review, see Beauchaine, 2015). However, the 
conditions under which it is measured have important interpretative implications.  
When RSA is measured while an individual is at rest, it is often termed basal 
RSA. Basal RSA serves as an index of resting vagal tone. Under resting conditions, 
polyvagal theory posits that the influence of the parasympathetic nervous system should 
be high; therefore, lower resting RSA indicates decreased physiological flexibility and a 
lower ability to adapt when faced with stressors (Porges, 1995; Porges, 2007). Empirical 
evidence has validated this theory, as higher basal RSA has been associated with more 
adaptive emotion regulation strategies (Gentzler, Santucci, & Fox, 2009), while low 
resting RSA has been associated with both internalizing and externalizing symptoms 
(Zisner & Beauchaine, 2015). 
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When RSA is measured during a stressor task, it is often termed RSA reactivity. 
RSA reactivity refers to the degree to which vagal tone changes during a challenging or 
stressful experience. Polyvagal theory posits that RSA reactivity is an index of an 
individual’s ability to adapt to environmental demands (Porges, 1995; Porges, 2007). 
Reductions in vagal tone indicate that the vagus nerve is withdrawing its inhibitory effect 
on cardiac functioning, indicating a decrease in parasympathetic nervous system activity. 
This allows the individual to utilize resources in order to meet the environmental demand 
he or she is being faced with. The relationship between RSA reactivity and 
psychopathology, however, remains unclear. For example, Beauchaine (2001) found that 
individuals with excessive RSA reactivity in addition to low basal RSA is indicative of 
emotion regulation difficulties. In contrast, other studies have shown that low RSA 
reactivity to stress, which has been theorized to be related to a low level of 
responsiveness to changing environmental demands, may also indicate poor emotion 
regulation skills (Zisner & Beauchaine, 2015). 
When RSA is measured following a stressor task, it is expected that RSA will 
return to resting levels. However, if this is not the case, an ongoing stress response may 
be present. This may be caused by a failure of an individual to employ adaptive emotion 
regulation strategies (Santucci et al., 2008). However, this measure of RSA is far less 
researched and understood than basal RSA, and its implications for psychopathology 
require further exploration. Regardless, investigating all three components of RSA (basal, 
reactivity, and recovery) measures the temporal course of emotional responsivity to a 
stressor over time, and provides a more complete understanding of an individual’s ability 
to regulate emotions as evidenced by their physiology (Santucci et al., 2008). 
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 Though basal RSA has been established as a transdiagnostic marker for a number 
of psychological disorders, no studies that I am aware of have examined the relationship 
between any measure of RSA and somatic symptoms or related disorders. There is, 
however, a strong association between somatic symptoms, depressive symptoms, and 
anxiety symptoms; thus the overlap among these conditions indicates that RSA will likely 
serve as a psychophysiological marker for somatic symptoms as well. Additionally, there 
is a significant body of literature to suggest that there is a relationship between somatic 
symptoms and other measures of physiologic dysregulation, including respiration 
(Grossman, 1983), hyperventilation (Troosters et al., 1999), and heart rate and end-tidal 
carbon dioxide pressure (Wientjes & Grossman, 1994). Thus, it is likely that RSA is also 
an important factor in the development and maintenance of somatic symptoms. 
Perseverative cognition and physiological activation. Perseverative cognition 
has previously been associated with a number of physiological measures of both 
sympathetic and parasympathetic nervous system activity, including heart rate, heart rate 
variability, skin conductance level, and blood pressure (Brosschot et al., 2003; Dua & 
King, 1987; Glynn et al., 2002; Lyonfields et al., 1995; Neumann et al., 2001; Roger & 
Jamieson, 1988; Schwartz et al., 2000; Segerstrom et al., 1999; Suchday et al., 2004; 
Thayer et al., 1996). With regard to RSA, a number of studies have indicated that 
perseverative cognition is associated with lower basal RSA. At least two studies have 
demonstrated that both experimentally induced and trait measures of worry are associated 
with decreased RSA (Lyonfields et al., 1995; Thayer et al., 1996). Additionally, 
Brosschot, van Dijk, and Thayer (2003) found that lower HRV was associated with 
periods of worry that occurred throughout the day during an ambulatory study. The 
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relationship between perseverative cognition and skin conductance level, however, is less 
well established. In fact, a several studies have reported null effects for the relationship 
between perseverative cognition and skin-conductance level (Dua & King, 1987; 
Segerstrom et al., 1999; Vickers & Vogeltanz-Holm, 2003). Though the literature in this 
area is limited, it is likely that there is an association between perseverative cognition and 
both increased sympathetic nervous symptom activity and decreased parasympathetic 
nervous system activity (Brosschot et al., 2006). 
The Present Study 
Brosschot and colleagues (2006) have proposed that perseverative cognition 
prolongs physiological activation in response to a stressor. This prolonged physiological 
activation is the mechanism through which they believe that perseverative cognition 
impacts somatic health. However, no studies have directly examined this explanatory 
pathway. The present study will examine this portion of the perseverative cognition 
hypothesis. I will first test the hypothesis that perseverative cognition will predict 
subsequent somatic symptoms, the way in which I have operationalized a pathogenic 
state, above and beyond depression and anxiety. Second, I will examine whether 
physiological activation, operationalized as RSA and EDR, will mediate this relationship. 
Each of these physiological measures will be collected before, during, and after 
participants complete a stressor task so that both tonic and phasic measures of 
sympathetic and parasympathetic nervous system activity can be accurately represented 
(Figure 2). Specifically, I hypothesized that physiological activation as defined by (a) 
lower basal RSA, (b) greater decreases in RSA in response to a stressor, (c) less return to 
basal RSA during the recovery period, (d) higher basal EDR, (e) greater increases in EDR 
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in response to a stressor, and (f) less return to basal EDR during the recovery period may 
explain the relationship between perseverative cognition and somatic symptoms. 
CHAPTER II 
Method 
Sample and Participant Selection 
 Sample Size.  The flexible nature of SEM allows for examination of complex 
associations, the use of various types of data, and comparison across models; however 
this flexibility has also resulted in difficulty in establishing guidelines for the sample size 
necessary to detect effects that are present in the data (Wolf, Harrington, Clark, & Miller, 
2013).  A number of rules of thumb have been proposed including a minimum N of 100 
or 200 (Boomsma, 1982; Boomsma, 1985), 5 or 10 observations for each parameter to be 
estimated (Bollen, 1989) and 10 cases per variable (Nunnally, Bernstein, & Berge, 1967). 
Based on these rules of thumb, estimates of the necessary sample size range from 100 to 
200. According to a guide provided by Fritz and MacKinnon (2007), when using bias-
corrected bootstrapping, approximately 148 participants are required to detect a small to 
moderate effect (0.26) for both the alpha and beta path of the mediation model. In the 
present study, 220 participants were enrolled. Data from five participants were excluded 
due to missing data on exogenous variables, resulting in a final sample size of 215 for the 
initially hypothesized models. Exact numbers of participants with data for each measure 
are included in Tables 3, 4, and 5. In posthoc analyses, 219 participants were included 
due to the elimination of exogenous variables from the model that had previously limited 
use of their data. 
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 Recruitment. Participants were recruited from introductory psychology courses 
at Seattle Pacific University where students receive course credit for enrolling in a 
research study. All students were eligible for the study if they were enrolled in the 
introductory psychology course and at least 18 years of age. 
 Participants. Participant (N = 220) demographics per self-report are presented in 
Table 1. Participants ranged in age from 18 to 39 years old (M = 19.63, SD = 12.10).  For 
the 2017 Autumn Quarter, the most recent statistics available, Seattle Pacific University 
(SPU) reported a total population of 2,911undergraduate students.  SPU reports that the 
average age of these students is 21, females represent 67% of the undergraduate 
population, and 40% of the undergraduate students fall under the broad category of 
“ethnic minority.”  The recruited sample has higher female representation than the 
undergraduate population.   The sample did have a comparable age range and racial and 
ethnic diversity of the whole undergraduate population sampled.      
Procedure 
 This dissertation was part of a larger study conducted by the Adolescent 
Cognition and Emotion (ACE) Lab at Seattle Pacific University entitled Stress and 
Somatic Symptoms in Young Adults (SASSY). The Seattle Pacific University 
institutional review board approved all study procedures and materials for SASSY. In the 
following section however, I will outline only those procedures and measures relevant to 
this dissertation. 
Participants were recruited from introductory psychology courses that took place 
from September, 2015 to March, 2017. Though students were recruited to participate at 
the beginning of the quarter, they were allowed to begin participation in the study at any 
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time in the quarter that would allow them to complete all portions of the study by the end 
of the quarter. Participants signed up for the research study using the online Sona 
platform used by Seattle Pacific University. Once students enrolled in Part 1 of the study, 
they completed a baseline questionnaire that included measures of trauma, depressive 
symptoms, somatic symptoms, anxiety, rumination, and worry. Following completion of 
the baseline questionnaire, participants were invited to enroll in Part 2 of the study by 
scheduling a laboratory visit. 
During the laboratory visit, researchers first reviewed the informed consent 
document with the participant. Once the participant provided consent by signing this 
form, the researcher attached eight self-adhering pre-gelled electrodes to the participant’s 
skin (one on the sternum; one on the lowest left rib; one on the lower back; one on the 
back of the neck; one on the collarbone; one on the front of the neck; and two on the 
bottom of the left foot). Each of these sensors was attached to a lead that was connected 
to a Biopac MP 150 Data Acquisition System (Biopac Systems, Inc., Goleta, CA). ECG 
and EDR signals were recorded using AcqKnowledge 4.1 software for the duration of the 
laboratory visit. 
After being hooked up to the physiological recording equipment, participants 
watched a series of nature scenes during which basal physiological measures were 
recorded. Next, participants were told that they had two minutes to prepare a speech on 
the topic of “Why are you a good friend?” that they may have to present. They were 
provided with a screen to type notes on for their speech that also indicated the amount of 
time remaining in the preparation period. Following this preparation period, the computer 
showed a screen indicating the condition to which the participant was randomized. 
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However, no participants were ever required to present their speech. After completing 
participation in the laboratory visit, participants were debriefed, and told that no 
participants ever had to give their speech. They were also provided with information on 
the empirical support for the use of this paradigm as a stressor task. Following the 
laboratory visit, participants were asked to complete six additional online questionnaires 
that included a measure of somatic symptoms. The participant completed one of the 
questionnaires every two to three days, providing longitudinal information about their 
somatic symptoms over the course of approximately two weeks. 
Measures 
Covariates. Previous research has indicated that there are strong correlations 
among depression, anxiety, and somatic symptoms (for a review, see Henningsen, 
Zimmermann, & Sattel, 2003). For example, Haug, Mykletun, and Dahl (2004) found 
significant correlations among anxiety, depressive, and somatic symptoms independent of 
age and gender in a sample of over 50,000 Norwegian individuals. As previously 
reviewed, there is also substantial evidence to suggest that both rumination and worry are 
related to depression and anxiety (Muris et al., 2005; Segerstrom et al., 2000). 
Additionally, as discussed above, trauma history is a well-established predictor of 
somatic symptoms (Roelofs & Spinhoven, 2007). Thus, baseline measures of depressive 
symptoms, anxiety, and trauma history will be included as covariates in all primary 
analyses in order to better understand the specific relationships of interest in the current 
investigation 
Center for epidemiological studies depression scale (CES-D). Depressive 
symptoms were measured at Part 1 with the Center for Epidemiological Studies 
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Depression scale (CES-D; Radloff, 1977).  The CES-D is a measure developed to assess 
depressive symptoms over the past week among adults with subclinical levels of 
depressive symptoms. The measure consists of 20 statements related to depressive 
symptoms. Sample items include: “I had crying spells,” “I felt that everything I did was 
an effort,” and “I felt hopeful about the future” (reverse scored item). Participants 
rated the frequency with which they experienced each symptom during the past 
week using a 4-point Likert scale ranging from 0 (rarely or none of the time [less than 1 
day]) to 3 (most or all of the time [5-7 days]).  Scores were calculated first by reverse-
scoring positively worded items and then summing the items to produce a total 
score.  Scores on the CES-D range from 0 to 60, with higher scores indicating a greater 
degree of depressive symptoms.  Scores above 16 suggests a significant level of 
depression (Radloff, 1977). The CES-D and is considered a valid measure of depressive 
symptoms, as it highly correlates with clinician ratings of depression (r = .53; Radloff, 
1977).  Cronbach’s alpha for the CES-D among college student samples ranges from .78 
to .87 (Radloff, 1991; Verhaeghen, Joorman, & Khan, 2005).  In the present study, the 
Cronbac’'s alpha was 0.72. 
Generalized anxiety disorder questionnaire – IV (GAD-Q-IV). Generalized 
anxiety symptoms were measured at Part 1 with the Generalized Anxiety Disorder 
Questionnaire – IV (GADQ-IV; Roemer, Posa, & Borkovec, 1995). The measure was 
developed as a screening device for generalized anxiety disorder, and has subsequently 
been revised based on DSM-IV criteria (Newman et al., 2002).  This measure consists of 
a number of items designed to determine whether an individual’s worry is distressing, 
uncontrollable, and often about minor things. Sample items include “Do you experience 
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excessive worry?” and “ Do you find it difficult to control your worry (or stop worrying) 
once it starts?” The sixth item of the questionnaire acts as a skip out item. It asks “During 
the last six months have you been bothered by excessive and uncontrollable worries more 
days than not?” If the individual responds “no” they are instructed to skip the three 
remaining questions, which further characterize the symptoms and functional impact of 
the individual’s worry. The GAD-Q-IV was scored according to the instructions outlined 
by Newman and colleagues (2002), yielding a sum total for each participant. This sum 
score can be compared to a cutoff rate of 5.7 to determine whether the individual may 
have Generalized Anxiety Disorder. The GAD-Q-IV has been established as an effective 
screening tool for Generalized Anxiety Disorder with a low false positive rate and a fairly 
low false negative rate (Newman et al., 2002). Because of the structure of the measure, it 
is not appropriate to assess internal consistency and item-total correlations for the GAD-
Q-IV. 
Brief trauma questionnaire (BTQ). Trauma history was measured at Part 1 with 
the Brief Trauma Questionnaire (BTQ; Schnurr, Vielhauer, Weathers, & Findler, 1999). 
The BTQ is a 10-item measure of trauma history. The measure consists of a ten prior life 
experiences that would be extraordinarily stressful or disturbing for almost everyone. 
Sample items include “Have you ever been in a serious car accident, or a serious accident 
at work or somewhere else?” and “Has anyone ever made or pressured you into having 
some type of unwanted sexual contact?” Participants will be asked to indicate “Yes” or 
“No” in response to each question. A count is taken of the number of items each 
participant responded yes to, with a potential score ranging from 0 to 10. While there is 
limited psychometric data for this measure, early evidence for its’ reliability and validity 
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have been promising (Lancaster, Melka, & Rodriguez, 2009; Schnurr et al., 1999). In a 
study of the reliability between the BTQ and an interview with a subset of participants, 
kappa coefficients for the existence of a history of traumatic events ranged from .60 to 
1.00. Kappas for eight of the items fell above .74 (Schnurr et al., 1999). 
Perseverative cognition. 
Ruminative response scale (RRS).  The RRS is a 22-item measure of rumination. 
Participants were asked to indicate how often they do each item when they are sad on a 
four-point scale from 1 (almost never) to 4 (almost always). Sample items include “think 
about a recent situation, wishing it had gone better,” “think about all your shortcomings, 
failings, faults, mistakes,” and “think about how angry you are with yourself.” The 
potential total sum scores range from 22 to 88. Additionally, two subscales (brooding and 
reflection) can be calculated (Treynor, Gonzalez, & Nolen-Hoeksema, 2003). A 
confirmatory factor analysis of the Dutch version of this measure indicated that a two-
factor structure provided adequate fit (Schoofs, Hermans, & Raes, 2010). Additionally, 
the RRS has demonstrated high internal consistency, with Cronbach’s alpha ranging from 
0.90 to 0.91 (Schoofs et al., 2010; Treynor et al., 2003). The internal consistency for each 
of the subscales are lower, but acceptable (α= 0.78 for the brooding subscale and α=0.75 
for the reflection subscale; Schoofs et al., 2010). In the present study, only the brooding 
subscale was used, and the Cronbach’s alpha was 0.78. 
Pennsylvania State worry questionnaire (PSWQ). The PSWQ is a 16-item 
measure of worry (Meyer, Miller, Metzger, & Borkovec, 1990). Participants were asked 
to indicate how typical each item is of them on a five-point scale from 1 (not at all typical 
of me) to 5 (very typical of me). Five of the items are reverse scored. Sample items 
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include “Many situations make me worry,” “I find it easy to dismiss worrisome 
thoughts,” (reverse scored), and “My worries overwhelm me.” The potential sum score 
ranges from 16 to 80. The PSWQ has demonstrated good internal consistency in previous 
studies (α =0.93; Brown, Antony, & Barlow, 1992). In the present study, Cronbach’s 
alpha was 0.73. 
Physiological activation. 
Electrodermal responding (EDR). A galvanic skin response (GSR) amplifier was 
used to measure sweat secretion linked with SNS activity through electrodermal 
responding (EDR).  The system assesses skin conductance based on the moisture level of 
the skin through two disposable electrodermal electrodes.  These electrodes were placed 
on the left foot directly beneath the big and little toes.  The area was cleaned and dried 
before attaching the electrodes and then secured with athletic tape around the foot and a 
sock.  Participants were asked to rest their foot in a stable position and to refrain from 
moving it as much as possible.  Specific settings on the GSR amplifier included a gain of 
5 micromho, along with a low pass filter at 10 Hz.  AcqKnowledge 4.1 software will be 
used to record EDR, and to apply a low pass filter and waveform math transformation to 
the raw data. EDR data will be processed using the Mindware EDA 3.0.20 analysis 
program. EDR was scored in 30-second epochs as the number of skin conductance 
responses from peak to valley that that exceeded 0.05 microsemens over a duration of at 
least one second. The number of responses was averaged across the 4-minute 
baseline (nature scene viewing), 2-minute stressor, and 3-minute recovery periods.  Each 
epoch was visually inspected and corrected as needed by trained research assistants. 
More responses indicated increased sympathetic nervous system activity.  
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Basal EDR was calculated as the mean number of EDR responses across 
baseline epochs (bEDR).  EDR reactivity to the stressor task (sEDR) was calculated 
by subtracting bEDR from the mean of EDR responses across the stressor task epochs. 
Positive EDR reactivity scores indicate an increase in the number of responses from 
baseline while negative EDR reactivity scores indicate a decrease in the number of 
responses from baseline.  EDR recovery (rEDR) was calculated by subtracting 
bEDR from the mean number of responses across the recovery period epochs. Positive 
EDR recovery scores indicate an increase in EDR from baseline while negative EDR 
recovery scores indicate a decrease in EDR from baseline (Zisner & Beauchaine, 2015). 
Respiratory sinus arrhythmia (RSA). Basal RSA, RSA reactivity, and RSA 
recovery data were acquired using ECG signals amplified and sampled continuously at 
1000 Hz with a Biopac MP150 Data Acquisition System (Biopac Systems, Inc., Goleta, 
CA).  AcqKnowledge 4.1 software was used to record ECG, which was measured using 
pre-gelled disposable Ag/AgCL electrodes placed in a Lead II configuration on the chest 
and abdomen.  Data was analyzed within the respiratory range of 0.15 to 0.50 Hz using 
spectral analysis and normalized with logarithmic transformations. ECG data was 
processed using the Mindware HRV 3.0.20 analysis program. RSA was scored in 30-
second epochs and averaged across the 4-minute baseline (nature scene viewing), 2-
minute stressor, and 3-minute recovery periods.  Each epoch was visually inspected and 
corrected as needed by trained research assistants. 
Basal RSA was calculated as the mean of RSA responses across 
baseline epochs (bRSA).  RSA reactivity to the stressor task (sRSA) was calculated 
by subtracting bRSA from the mean of RSA responses across the stressor task epochs. 
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Positive RSA reactivity scores indicate an increase in RSA from baseline while negative 
RSA reactivity scores indicate a decrease in RSA from baseline.  RSA recovery (rRSA) 
was calculated by subtracting bRSA from the mean of RSA responses across the recovery 
period epochs. Positive RSA recovery scores indicate an increase in RSA from baseline 
while negative RSA recovery scores indicate a decrease in RSA from baseline (Zisner & 
Beauchaine, 2015). 
Somatic symptoms. 
Patient health questionnaire – 15 (PHQ-15). The PHQ-15 (Kroenke, Spitzer, & 
Williams, 2002) is a 15-item measure of somatic symptoms. The measure consists of a 
list of symptoms including “Stomach pain,” “Headaches,” and “Shortness of breath.” 
Participants were asked to indicate the level at which they were bothered by each 
symptom on a scale ranging from 0 (not bothered at all) to 2 (bothered a lot). At 
baseline, participants were asked to indicate this for symptoms over the past four weeks. 
On the daily surveys, participants were asked to indicate this for symptoms since the last 
time they had completed the survey. The potential sum scores range from 0 to 30. The 
PHQ-15 has demonstrated adequate internal consistency in previous studies (α =0.79)and 
evidence for good validity in non-Hispanic populations (Interian, Allen, Gara, Escobar, & 
Díaz-Martínez, 2006). In the present study, Cronbach’s alpha values ranged from 0.78 to 
0.87. 
Data Analytic Plan 
SPSS 24 was used to prepare and examine data prior to testing the primary 
hypotheses of this study. Specifically, an analysis of normality and outliers was 
conducted and descriptive statistics were calculated. Additionally, correlations among 
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variables were examined. Mplus 7 was used to conduct confirmatory factor analysis in 
order to examine the fit of all latent variables: rumination, worry, perseverative cognition, 
and somatic symptoms.  Additionally, Mplus 7 was used to examine the mediating role of 
six physiological measures (basal EDR, EDR reactivity, EDR recovery, basal RSA, RSA 
reactivity, and RSA recovery) between trait perseverative cognition (a latent variable 
consisting of both worry and rumination) and subsequent somatic symptoms. The 
hypothesized mediational relationships of EDR and RSA were tested separately. Each 
model included measures of the physiological mediator at baseline, during the stressor 
task, and during the recovery period (Figures 3a and 3b). Because physiological measures 
during the stressor task and recovery period were entered as change scores from baseline, 
the three mediators were not allowed to covary. Mplus 7 provided tests of overall model 
fit, standardized coefficients for each path, and tests of direct and indirect effects for both 
models with depression, anxiety, biological, and trauma history included as covariates.  
  




Preliminary Analysis  
Prior to testing my proposed model, I inspected the data for missing data, normality of 
distribution and outliers.  Descriptive statistics are described below. 
Data Preparation. There were 220 participants who enrolled in the study. No 
data imputation was used at the raw data level.  Instead, scale scores were calculated 
when individuals completed 80% of the items in the measure.  Using these guidelines, 
215 participants had complete data on all baseline variables and were included in the 
primary analyses, as Mplus allows for missing data on endogenous variables. All 
available data is used to estimate the model using full information maximum likelihood; 
each parameter is estimated directly without first filling in missing data values (Muthén 
& Muthén, 2017).  Though data from 215 participants was included in these analyses, it 
is important to note that not all participants completed all measures. 164 participants had 
complete data for RSA variables collected during the laboratory visit and 163 had 
complete data for EDR variables collected during the laboratory visit. Additionally, 150 
participants completed at least five of the six daily questionnaires. Exact numbers of 
participants with data for each measure are included in Tables 3, 4, and 5. In posthoc 
analyses, 219 participants were included due to the elimination of exogenous variables 
from the model that had previously limited use of their data. 
Normality and outlier analysis.  Outliers were assessed graphically through 
stem-and-leaf plots as well as through visual inspection of the raw data. There was 
sufficient evidence to support deleting two problematic outliers.  One participant’s data 
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(ID #239) for RSA was coded as missing in all subsequent analyses, as the values for 
their RSA were far below the normally observed range.  Similarly, one participant’s data 
(ID# 228) for EDR was far above the normally observed range, and was coded as missing 
in all subsequent analyses. 
Normality was assessed graphically through histograms (see Table 2), normal 
curves, P-P plots, Q-Q plots and box plots.  It was assessed numerically through 
skewness and kurtosis output and computed standardized z-scores.  Normality was also 
assessed the Shapiro-Wilk test of normality (S-W test; Field 2005).  Scores on Basal RSA 
and EDR during stressor did not significantly differ from the normal distribution. The 
distribution of all other scores used for analyses were significantly different than normal 
(see Table 2).  I examined variables that showed skewness and kurtosis (Table 2).  
Positive skewness values indicate scores lean to the left of the distribution and negative 
skewness values indicate the scores lean to the right. Positive kurtosis values indicate 
more weight in the tails while negative kurtosis values indicate less weight in the tails 
compared to what would be expected with normal distribution (Westfall, 2014). In order 
to address the non-normal nature of my data, bootstrapping procedures as recommended 
by Preacher & Hayes (2008) were used. Bootstrap resampling uses the sample as a 
population from which many random samples are drawn and continuously replaced so 
that they have an equal likelihood of being randomly selected on all subsequent drawings 
(Mallinckrodt et al., 2006).  The bootstrap resampling procedure increases power by 
providing non-symmetric confidence intervals, reducing the likelihood of making a Type 
II error. Additionally, bootstrapping does not assume normality of the sampling 
distribution. 
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 Descriptive Statistics.  Bivariate correlations, means, and standard deviations for 
baseline study variables are presented in Table 3, descriptive data for the lab visit 
variables are presented in Table 4, and descriptive data for the average daily measures in 
the daily questionnaires are presented in Table 5.   
Baseline.  As expected, both trait worry and trait rumination were positively 
correlated with depressive symptoms and anxiety symptoms. However, only trait 
rumination was associated with trauma history. Additionally, sex was associated with 
both trait worry and trait rumination (see Table 3), and was included as a covariate when 
fitting the hypothesized model. 
Lab Visit. All measures of RSA were positively correlated with one another, and 
all measures of EDR were positively correlated with one another as expected (see Table 
4). Additionally, no RSA measures were correlated with EDR measures. RSA during the 
stressor was also positively correlated with age. 
Weekly.  Biological sex correlated with somatic symptoms on days one through 
four, but not five and six.  As expected, all measures of somatic symptoms were positively 
correlated with one another (see Table 5). 
Confirmatory Factor Analyses. Prior to testing the proposed mediation model, I 
performed confirmatory factor analyses for all latent variables: rumination, worry, 
perseverative cognition, and somatic symptoms. According to guidelines published by 
Schreiber, Nora, Stage, Barlow, & King (2006), in order for a model to have adequate fit, 
relative c2 ratios should be less than 2, comparative fit index (CFI) values should be at 
least 0.95, root mean square error of approximation (RMSEA) values should be less than 
0.06, and standardized root mean square residual (SRMR) should be less than 0.08. When 
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adequate model fit was not observed, changes were made to model fit were determined 
through examination of modification indices, and evaluation of the consistency of these 
potential changes with the theoretical underpinnings of the measure. Alternative models 
were compared using the Akaike information criterion and Bayes information criterion as 
suggested by Schreiber and colleagues (2006) for non-nested models. For both of these 
criterions, smaller values indicate improved model fit. 
Based on these analyses, worry was modeled as a two-factor structure as this was 
a better fit for the data (see Table 6, Figure 4b). The two factors were based on the 
structure of the measure, with reverse-coded items making up a separate factor from 
items that were not reverse coded. Both rumination and somatic symptoms were modeled 
as single factors (Figure 4a and 4c respectively). For both worry and rumination, items 
were allowed to covary based on a combination of modification indices and similarity of 
item content.  Additionally, measures of somatic symptoms were allowed to covary 
among consecutive days, given that less change in symptom report is expected over a 
shorter time period (Figure 4). 
Primary Analyses 
Tests of Model Fit for RSA.  I assessed my hypothesized RSA model using 
MPlus 7.  I first evaluated the adequacy of the hypothesized model by examining the fit 
statistics including the chi-square (c2) likelihood ratio statistic, relative c2 ratios, CFI, 
RMSEA, and SRMR.  The fit indices were: c2(505) =931.42, p < 0.001; c2 Ratio = 1.84; 
CFI = 0.88; RMSEA = 0.06; SRMR = 0.21.   
Tests of Direct and Indirect Effects for RSA.  Once adequate model fit was 
established, I assessed the joint effects of multiple mediators using bootstrap resampling 
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procedures (Mallinckrodt et al., 2006; Preacher & Hayes, 2008).  I specified 5000 
bootstrap iterations and used 95% bias-corrected confidence intervals (Figure 5a). 
Specific direct effects, indirect effects, and total effects are discussed below and reported 
in Table 7.   
C’ path: Did trait perseverative cognition predict daily somatic symptoms?  Trait 
perseverative cognition significantly predicted daily somatic symptoms (β = -0.23, p = 
0.001). However, this relationship was in the unexpected direction, such that individuals 
with higher levels of perseverative cognition experienced fewer somatic symptoms, after 
controlling for anxiety symptoms, depressive symptoms, trauma history, and biological 
sex.  
A paths: Did trait perseverative cognition predict RSA? Within the hypothesized 
model, perseverative cognition did not significantly predict basal RSA (β = -0.01, p = 
0.956), RSA reactivity (β = -0.12, p = 0.147), or RSA recovery (β = -0.11, p = 0.269). 
B paths: Did RSA predict daily somatic symptoms?  Within the hypothesized 
model, basal RSA (β = -0.08, p = 0.202) and RSA recovery (β = 0.067, p = 0.267) did not 
significantly predict somatic symptom. RSA reactivity was trending (β = 0.09, p = 0.099) 
such that individuals who experienced less of a decrease in RSA during the stressor task 
were more likely to experience somatic symptoms. 
Indirect effects.  Within the full model, RSA did not mediate the relationship 
between perseverative cognition and somatic symptoms. This was true for basal RSA (β 
= 0.00, p = 0.967), RSA reactivity (β = -0.01, p = 0.343), and RSA recovery (β = -0.01, p 
= 0.486). 
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Tests of Model Fit for EDR.  I assessed my hypothesized EDR model using 
MPlus 7.  I first evaluated the adequacy of the hypothesized model by examining the fit 
statistics including the chi-square (c2) likelihood ratio statistic, relative c2 ratios, CFI, 
RMSEA, and SRMR.  The fit indices were: c2(505) = 1010.20, p <0.001; c2 Ratio = 
2.00; CFI = 0.86; RMSEA = 0.07; SRMR = 0.20.  
Tests of Direct and Indirect Effects for EDR.  Once adequate model fit was 
established, I assessed the joint effects of multiple mediators using bootstrap resampling 
procedures (Mallinckrodt et al., 2006; Preacher & Hayes, 2008).  I specified 5000 
bootstrap iterations and used 95% bias-corrected confidence intervals (Figure 5b). 
Specific indirect effects, total effects, and direct effects are discussed below and reported 
in Table 8.   
C’ path: Did trait perseverative cognition predict daily somatic symptoms?  Trait 
perseverative cognition did not significantly predict daily somatic symptoms (β = -0.23, p 
= 0.074). Similar to the RSA model, though this relationship was not significant it was 
trending in the unexpected direction, such that individuals with higher levels of 
perseverative cognition experienced fewer somatic symptoms, after controlling for 
anxiety symptoms, depressive symptoms, trauma history, and biological sex.  
A paths: Did trait perseverative cognition predict EDR? Within the hypothesized 
model, perseverative cognition did not significantly predict EDR. This was true for basal 
EDR (β = -0.10, p = 0.430), EDR reactivity (β = 0.18, p = 0.144), and EDR during the 
recovery period (β = 0.06, p = 0.634). 
 B paths: Did EDR predict daily somatic symptoms?  Within the full model, EDR 
did not significantly predict somatic symptoms. This was true for EDR at baseline (β = -
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0.03, p = 0.688), EDR reactivity (β = -0.06, p = 0.546), and EDR during the recovery 
period (β = 0.07, p = 0.341). 
Indirect effects.  Within the full model, EDR did not mediate the relationship 
between perseverative cognition and somatic symptoms. This was true for EDR at 
baseline (β = 0.00, p = 0.926), EDR reactivity (β = -0.01, p = 0.846), and EDR during the 
recovery period (β = 0.00, p = 0.876). 
Post Hoc Analyses 
In both of the models tested, the relationship between perseverative cognition and 
somatic symptoms was in the unexpected direction given apriori theory and prior 
research. From a theoretical standpoint, one possible explanation for this is that the 
variance in somatic symptoms related to the problematic aspects of perseverative 
cognition may have significant overlap with the variance accounted for by measures of 
symptoms of anxiety and depression. Thus, after depression and anxiety are controlled 
for, only adaptive aspects of perseverative cognition (such as problem solving) remain 
and have a negative association with somatic symptoms. In order to evaluate this 
possibility, MPlus 7 was used to assess the total effect of perseverative cognition on 
somatic symptoms while excluding measures of depression and anxiety separately and 
together. Model fit was then compared to the initially hypothesized total effect. Results of 
these analyses are presented in Table 9. Excluding both the GAD and CES-D (measures 
of anxiety and depression, respectively) provided a total effect that indicated adequate 
model fit by more indices than the hypothesized model. Additionally, in this model the 
relationship between perseverative cognition and somatic symptoms was in the expected 
direction. These results are consistent with significant overlap of the variance accounted 
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for by measures of anxiety, depression, and perseverative cognition. The primary 
analyses were run once again without the inclusion of depression and anxiety as 
covariates in order to evaluate the role of sympathetic and parasympathetic nervous 
system activity as an explanatory factor in the relationship between perseverative 
cognition and somatic symptoms. 
Tests of Model Fit for RSA.  I first evaluated the adequacy of the alternative 
model by examining the fit statistics including the chi-square (c2) likelihood ratio 
statistic, relative c2 ratios, CFI, RMSEA, and SRMR.  The fit indices were: c2(447) 
=629.99, p < 0.001; c2 Ratio = 1.41; CFI = 0.95; RMSEA = 0.06; SRMR = 0.08.   
Tests of Direct and Indirect Effects for RSA.  Once adequate model fit was 
established, I assessed the joint effects of multiple mediators using bootstrap resampling 
procedures (Mallinckrodt et al., 2006; Preacher & Hayes, 2008).  I specified 5000 
bootstrap iterations and used 95% bias-corrected confidence intervals (Figure 6a). 
Specific direct effects, indirect effects, and total effects are discussed below and reported 
in Table 10.   
C’ path: Did trait perseverative cognition predict daily somatic symptoms?  Trait 
perseverative cognition significantly predicted daily somatic symptoms (β = 0.38, p < 
0.001) such that individuals with higher trait-level perseverative cognition experienced 
more somatic symptoms after controlling for trauma history and biological sex.  
A paths: Did trait perseverative cognition predict RSA? Within the alternative 
model, perseverative cognition did not significantly predict basal RSA (β = -0.01, p = 
0.945), RSA reactivity (β = -0.12, p = 0.144), or RSA recovery (β = -0.11, p = 0.265). 
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B paths: Did RSA predict daily somatic symptoms?  Within the alternative 
model, basal RSA (β = -0.10, p = 0.275), RSA reactivity (β = 0.03, p = 0.711), and RSA 
recovery (β = 0.12, p = 0.173) did not significantly predict somatic symptom. 
Indirect effects.  Within the alternative full model, RSA did not mediate the 
relationship between perseverative cognition and somatic symptoms. This was true for 
basal RSA (β = 0.00, p = 0.961), RSA reactivity (β = -0.00, p = 0.786), and RSA 
recovery (β = -0.01, p = 0.433). 
Tests of Model Fit for EDR.  I assessed my alternative EDR model using MPlus 
7.  I first evaluated the adequacy of the hypothesized model by examining the fit statistics 
including the chi-square (c2) likelihood ratio statistic, relative c2 ratios, CFI, RMSEA, 
and SRMR.  The fit indices were: c2(447) = 702.62, p <0.001; c2 Ratio = 1.57; CFI = 
0.93; RMSEA = 0.05; SRMR = 0.08.  
Tests of Direct and Indirect Effects for EDR.  Once adequate model fit was 
established, I assessed the joint effects of multiple mediators using bootstrap resampling 
procedures were used (Mallinckrodt et al., 2006; Preacher & Hayes, 2008).  In the present 
study, 5000 bootstrap iterations were specified and 95% bias-corrected confidence 
intervals were used (Figure 6b). Specific indirect effects, total effects, and direct effects 
are discussed below and reported in Table 11.   
C’ path: Did trait perseverative cognition predict daily somatic symptoms?  Trait 
perseverative cognition significantly predicted daily somatic symptoms (β = 0.37, p = 
0.003) such that individuals with higher trait-level perseverative cognition experienced 
more somatic symptoms after controlling for trauma history and biological sex.  
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A paths: Did trait perseverative cognition predict EDR? Within the hypothesized 
model, perseverative cognition did not significantly predict basal EDR (β = -0.09, p = 
0.748) or EDR during the recovery period (β = 0.06, p = 0.591). EDR reactivity was 
trending (β = 0.18, p = 0.098) such that individuals with more perseverative cognition 
were more likely to experience an increase in EDR during the stressor task. 
B paths: Did EDR predict daily somatic symptoms?  Within the full model, EDR 
did not significantly predict somatic symptoms. This was true for EDR at baseline (β = -
0.03, p = 0.748), EDR reactivity (β = -0.11, p = 0.303), and EDR during the recovery 
period (β = 0.07, p = 0.514). 
Indirect effects.  Within the full model, EDR did not mediate the relationship 
between perseverative cognition and somatic symptoms. This was true for EDR at 
baseline (β = 0.00, p = 0.917), EDR reactivity (β = -0.02, p = 0.711), and EDR during the 
recovery period (β = 0.00, p = 0.870). 
Individual Mediators. I analyzed prospective mediation models of each mediator 
separately while continuing to control for biological sex and trauma history. The results 
of these individual mediations are presented in Table 12 (RSA) and Table 13 (EDR). As 
expected, perseverative cognition significantly predicted somatic symptoms such that 
individuals who engaged in more perseverative cognition were more likely to experience 
somatic symptoms in all mediation models. These analyses did not reveal any significant 
mediation pathways. However, the relationship between basal RSA and somatic 
symptoms was trending toward significance such that individuals with lower basal RSA 
reported more somatic symptoms (β = -0.15; p = 0.064). Contrary to our hypotheses, the 
relationship between RSA during the stressor and somatic symptoms was trending toward 
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significance such that individuals who experienced greater increases in RSA were more 
likely to report a lower level of subsequent somatic symptoms (β = 0.11; p = 0.099). 
Similarly, RSA during the recovery period significantly predicted subsequent somatic 
symptoms (β = 0.16; p = 0.029) such that individuals whose RSA was elevated above 
their baseline following the stressor were less likely to experience somatic symptoms. 
With regard to EDR, perseverative cognition significantly predicted EDR such that 
individuals who were more likely to engage in perseverative cognition experienced a 
greater increase in EDR during the stressor task (β = 0.17; p = 0.041). However, EDR did 
not remain elevated during the recovery period as hypothesized, indicating that the 
physiological arousal associated with the stressor task did not persist beyond the 
immediate impact of the stressor.  




 Many theories of somatization focus on worry about one’s health as a key factor 
in the development and maintenance of somatic symptoms. Brosschot, Gerin, and Thayer 
(2006) have broadened this focus on worry about physical symptoms as a perpetuating 
factor in somatic symptoms to include all perseverative cognition (e.g. worry and 
rumination). They posit that the key component in the development of somatic symptoms 
is not the act of worrying about health specifically, but the perseverative nature of these 
thoughts that result in prolonged physiological activation that may be interpreted as 
somatic symptoms. The purpose of the present study was to better understand the 
relationship between perseverative cognition and somatic symptoms. Specifically, I 
sought to examine whether prolonged physiological activation serves as an explanatory 
factor in the relationship between perseverative cognition and somatic symptoms. First, I 
hypothesized that perseverative cognition would prospectively predict somatic symptoms 
above and beyond anxiety and depression such that individuals who have a greater 
tendency to engage in perseverative cognition would experience more somatic symptoms.  
Perseverative cognition was measured prior to the stressor tasks, while somatic symptoms 
were measured during the two weeks following the stressor task. Second, I hypothesized 
that physiological activation, operationalized as RSA and EDR, would mediate this 
relationship.  Each of these physiological measures was collected before, during, and 
after participants completed a stressor task so that both tonic and phasic measures of 
sympathetic and parasympathetic nervous system activity were accurately represented. 
Overall, my study examined the hypothesis that the mechanisms through which 
perseverative cognition is predictive of somatic symptoms are heightened sympathetic 
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nervous system activity and reduced parasympathetic nervous system activity. With 
regard to parasympathetic nervous system activity, I hypothesized that individuals with 
higher levels of perseverative cognition would have lower basal RSA, experience greater 
decreases in RSA (disengagement of the parasympathetic nervous system) in response to 
a stressor, and failure of RSA to return to baseline levels during the recovery period 
(indicating failure of the parasympathetic nervous system to re-engage). Additionally, I 
predicted that individuals with these patterns of parasympathetic response to a stressor 
would experience higher levels of subsequent somatic symptoms. With regard to 
sympathetic nervous system activity, I hypothesized that individuals with higher levels of 
perseverative cognition would have higher basal EDR, experience greater increases in 
EDR during a stressor (indicating over engagement of the sympathetic nervous system), 
and failure of EDR to return to baseline levels during the recovery period (indicating 
prolonged activation of the sympathetic nervous system). 
 This study makes a number of unique contributions to the literature on somatic 
symptoms. First, because somatic complaints are a common reason patients present for 
medical care (Janca, Isaac, & Ventouras, 2006), it is important to understand the 
cognitive and physiological vulnerabilities that lead some individuals to report more 
somatic symptoms than others. Additionally, though several studies have examined the 
relationship between perseverative cognition and somatic symptoms, it has previously 
been unclear whether this relationship would remain after controlling for depression and 
anxiety. Finally, prior to this study, there has been only very limited evidence for the 
relationship between EDR and somatic symptoms, and no published examination of the 
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relationship between RSA and somatic symptoms. In the following sections, I will 
describe the outcomes of my hypotheses. 
Did perseverative cognition predict subsequent somatic symptoms? 
My hypothesis that the positive relationship between perseverative cognition and 
somatic symptoms would remain after controlling for depression and anxiety was not 
supported. However, perseverative cognition did significantly predict somatic symptoms 
in the expected direction when anxiety and depression were not included as covariates. 
This is consistent with previous studies that have found an association between worry or 
rumination and somatic symptoms without controlling for anxiety or depression 
(Borkovec, 1994; Brosschot & Van Der Doef, 2006; Freeston et al, 1996; Lok & Bishop, 
1999; Rector & Roger, 1996; Thomsen et al., 2004). Additionally, this finding is not 
surprising given the overlap of symptomology among anxiety, depression, and somatic 
symptoms. For example, a population-based analysis of the overlap of symptoms in these 
categories found that among 2510 individuals who reported a high level of symptoms in 
one of these areas, 36.4% of cases had a high level of symptoms in another area as well 
(Kohlmann, Gierk, Hilbert, Brähler, & Löwe, 2016). Similarly, a cross-sectional study 
comparing somatic symptoms among individuals depressive or anxiety disorder to 
controls found that somatic symptoms were more prevalent among patients with anxiety 
or depression than among controls (Bekhuis, Boschloo, Rosmalen, & Schoevers, 2015). 
It is also important to note that, in the present study, after controlling for anxiety 
and depression, the relationship between perseverative cognition and somatic symptoms 
was significant in the unexpected (negative) direction. It is likely that the variance in 
somatic symptoms related to the problematic aspects of perseverative cognition may have 
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significant overlap with the variance accounted for by measures of symptoms of anxiety 
and depression. Thus, after depression and anxiety are controlled for, only adaptive 
aspects of perseverative cognition (such as problem solving) remain. These adaptive 
aspects of perseverative cognition would then be expected to have a negative association 
with somatic symptoms, as was found in the present study. In the current literature, there 
are not any studies I am aware of that have directly examined the relationship between 
perseverative cognition and adaptive cognitive strategies.  Similarly, though many studies 
have examined rumination as a maladaptive cognitive strategy, I am not aware of any 
studies that have specifically examined the relationship between rumination and more 
adaptive cognitive strategies. However, there are several studies which suggest that worry 
does not necessarily preclude adaptive problem-solving strategies. For example, a study 
of children who reported elevated levels of worry compared to their peers did not display 
deficits in problem-solving skills (Parkinson & Creswell, 2011). Though worry may be 
associated with problem solving orientation, it is not necessarily predictive of problem 
solving skills (Dugas, Letarte, Rhéaume, Freeston, & Ladouceur, 1995). Among 
individuals with GAD, use of maladaptive problem solving strategies seems to be 
dependent on emotional state (Pawluk, Koerner, Tallon, & Antony, 2017). 
Did physiological activation mediate the relationship between perseverative 
cognition and somatic symptoms? 
First, my hypothesis that basal RSA, RSA reactivity, and RSA recovery would 
together mediate the relationship between perseverative cognition and somatic symptoms 
was not supported. This was true regardless of whether anxiety and depression were 
included as covariates. Post-hoc analysis of individual mediations indicated that when 
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depression and anxiety were not included in the model, there was not a significant 
association between perseverative cognition and RSA. Interestingly, this is contrary to 
the findings of a recent meta-analysis of the physiological concomitants of perseverative 
cognition (Ottaviani et al., 2016). Specifically, analyses of 18 experimental studies and 
eight correlational studies both indicated an overall association between perseverative 
cognition and decreased heart rate variability. One potential explanation for this is that 
many of the studies that resulted in significant changes in heart rate variability responses 
to perseverative cognition used state measures of perseverative cognition, while studies 
using trait measures of perseverative cognition (such as ours) did not yield significant 
results. Future studies of this relationship should include both state and trait measures of 
perseverative cognition in order to provide a better understanding of the differential and 
combined effects of both state and trait perseverative cognition on somatic symptoms. 
Post-hoc analyses of individual mediations did indicate that the relationship 
between basal RSA and somatic symptoms was trending toward significance such that 
lower basal RSA predicted greater subsequent report of somatic symptoms. This is 
consistent with previous studies that have found that cardiac autonomic functioning is 
differentially related to somatic symptoms of depression in patients with stable coronary 
artery disease (de Jonge, Mangano, & Whooley, 2007), adults over the age of 52 (Tak, 
Janssens, Dietrich, Slaets, & Rosmalen, 2010) and preadolescents (Bosch, Riese, Ormel, 
Verhulst, & Oldehinkel, 2009). The present study indicates that this finding could be 
extended to a novel population, college students.  However, the relationship between 
RSA reactivity was trending toward significance such that greater decreases in RSA 
predicted lower report of subsequent somatic symptoms. Similarly, RSA recovery 
PERSEVERATIVE COGNITION AND SOMATIC SYMPTOMS  50 
 
significantly predicted somatic symptoms such that individuals whose RSA remained 
farther below their baseline reported higher rates of subsequent somatic symptoms. This 
is contrary to our hypotheses that individuals whose parasympathetic nervous system 
overreacted to the stressor task and then failed to re-engage following the stressor task 
would experience higher levels of subsequent somatic symptoms. In fact, this study 
revealed that individuals whose parasympathetic nervous system displayed less 
engagement during the stressor period and greater engagement during the recovery period 
following the stressor experienced higher levels of subsequent somatic symptoms. One 
possible explanation for this is that medical conditions were a confounding factor. As 
medical conditions were not measured in the present study, they may account for some of 
the symptoms participants reported the PHQ-15. With regard to RSA reactivity, one 
possibility is that a blunted RSA response is predictive of subsequent somatic symptoms. 
A number of previous studies have suggested that there is a “U-shaped” relationship 
between RSA and internalizing psychopathology such as major depressive disorder 
(Bylsma, Salomon, Taylor-Clift, Morris, & Rottenberg, 2014; Rottenberg, Clift, Bolden, 
& Salomon, 2007; Yaroslavsky, Bylsma, Rottenberg, & Kovacs, 2013). The findings 
from the present study indicate that a blunted, rather than elevated, RSA response may be 
related to somatic symptoms. With regard to RSA recovery, individuals with blunted 
RSA responses to a stressor would have less of a change in parasympathetic nervous 
system engagement to recover from. Another possibility is that though the 
parasympathetic nervous system re-engages effectively following a stressful event, 
individuals who are prone to somatic symptoms may be hypervigilant to any bodily 
changes (increased digestion, decreased heart rate, etc.) misinterpret these changes as 
PERSEVERATIVE COGNITION AND SOMATIC SYMPTOMS  51 
 
somatic symptoms. Additionally, it may be important to explore alternate ways of 
considering the role of physiological arousal measured via RSA, such as the interaction 
of RSA measurements across phases of the stressor task. Though RSA reactivity and 
recovery did not predict somatic symptoms in the expected direction, the pattern of 
parasympathetic response to a stressor may be an important predictor of somatic 
symptoms. Overall, the results of the present study indicate that the role of RSA in 
somatic symptoms warrants further explanation. 
Second, my hypothesis that basal EDR, EDR reactivity, and EDR recovery would 
together mediate the relationship between perseverative cognition and somatic symptoms 
was not supported. This was true regardless of whether anxiety and depression were 
included as covariates. Post-hoc analysis of individual mediations also indicated that 
when depression and anxiety were not included in the model, neither basal EDR nor EDR 
recovery were significantly associated with perseverative cognition.  This is consistent 
with several studies have reported null effects for the relationship between perseverative 
cognition and skin-conductance level (Dua & King, 1987; Segerstrom et al., 1999; 
Vickers & Vogeltanz-Holm, 2003). However, perseverative cognition did significantly 
predict EDR reactivity such that individuals who were more likely to engage in 
perseverative cognition exhibited greater increases in EDR responses during the stressor 
task. In the present study, these findings indicate that individuals with a greater tendency 
to engage in perseverative cognition did so during the stressor task, resulting in elevated 
sympathetic nervous system responding. This is consistent with previous literature that 
individuals with symptoms of internalizing disorder (such as depression and anxiety) 
exhibit greater electodermal activity when compared to a control group (Zisner & 
PERSEVERATIVE COGNITION AND SOMATIC SYMPTOMS  52 
 
Beauchaine, 2015). However, EDR reactivity did not significantly predict somatic 
symptoms. This is contrary to the perseverative cognition hypothesis, which posits that 
prolonged physiological activation is the mechanism by which stress is translated into a 
pathogenic state such as somatic symptoms. One potential explanation for this is that the 
present study used a laboratory stressor of speech preparation in order to provoke a stress 
reaction from participants. I assumed that individuals have a tendency to perseverate 
would do so in this context; however, I did not measure this directly. It is possible that 
even individuals with a tendency to perseverate did not continue to engage in 
perseverative thoughts about this stressor during the allowed recovery period, and thus 
did not experience continued physiological arousal. Future studies should seek to 
examine physiological arousal in response to spontaneous perseveration about authentic 
stressors. Additionally, a state measure of perseverative cognition may provide additional 
insight in to the relationship between perseverative cognition and EDR. 
Clinical Application 
 A number of studies, including this one, have demonstrated a strong relationship 
between perseverative cognition and somatic symptoms. When attempting to treat 
patients with somatic symptoms, it is important for clinicians to address the relationship 
between cognition and these symptoms, rather than simply treating the physical ailments 
the patient is presenting with. Additionally, the results of this study suggest that there is 
significant overlap between the symptoms of anxiety, depression, and somatic symptoms. 
Therefore, when a patient presents with a complaint of somatic symptoms, it is also 
important to screen for and treat any underlying anxiety or depressive disorder that may 
be contributing to the manifestation of somatic symptoms. 
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 This study also demonstrated that trait perseverative cognition is associated with 
increased activation of the sympathetic nervous system (as measured by EDR) during a 
stressor. While not empirically tested in the context of this study, it is likely that people 
who tend to engage in more perseverative cognition were likely engaging in perseverative 
cognition during the stressor task, resulting in greater increases in electrodermal 
responding. From a cognitive behavioral perspective, this underlines the importance of 
teaching patients more adaptive cognitive strategies to be used during stressors in order to 
limit activation of the sympathetic nervous system. Additionally, contrary to my 
hypothesis, re-engagement of the parasympathetic nervous system to after a stressor (as 
measured by RSA) was associated with higher reports of subsequent somatic symptoms. 
This indicates that individuals who are prone to somatic symptoms may be hypervigilant 
to any bodily changes, including those associated with parasympathetic activity 
(increased digestion, decreased heart rate, etc.), and misinterpret these changes as somatic 
symptoms. Clinically, patients may benefit from interventions that allow for 
normalization of bodily sensations such as biofeedback and cognitive restructuring. 
Limitations and Future Directions 
 There are several limitations to consider in the interpretation of the results from 
this study. First, participants in the present study were college students, who were 
generally young, healthy, Caucasian females. Thus, the results cannot necessarily be 
generalized to other populations including those of other races, ages, sexes, or who have 
medical or psychiatric diagnoses. Future research should examine these variables in 
clinical populations, as well as among samples that are more diverse with regard to age, 
race/ethnicity, and sex. Second, the majority of measures in this study were self-report. 
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Thus, the information provided may not be reliable. Additionally, the self-report 
measures used in this study have considerable overlap in item content. For example, the 
PSWQ and GAD-IV both emphasize the role of worry, making it difficult to tease out the 
difference between anxiety (a planned covariate) and worry (an aspect of perseverative 
cognition). Future studies of the relationship between somatic symptoms that seek to 
control for depression and anxiety should consider developing more clearly delineated 
operational definitions of each construct and choose measures (or items from measures) 
accordingly. Third, though our study was prospective in nature, the time-frame that 
measures were administered across was relatively short. Additionally, perseverative 
cognition was measured only as a trait variable at baseline. Though somatic symptoms 
were assessed at six time points, we did not examine fluctuations in reporting of these 
symptoms over time.  Therefore, it is possible that fluctuations in perseverative cognition 
over time are associated with fluctuations in somatic symptoms over time. Future 
research should continue to utilize prospective experimental designs and data analytic 
strategies in order to further examine the causal relationship between perseverative 
cognition and somatic symptoms. Fourth, though the measures of RSA and EDR were 
successive, in the present study they were treated as concurrent mediators. Future 
research should examine whether patterns of autonomic responding over time provide an 
explanation for the established relationship between perseverative cognition and somatic 
symptoms.  Finally, the present study did not examine the combined impact of 
sympathetic and parasympathetic functioning as a mediator of this relationship. Notably, 
we found associations between perseverative cognition and EDR, as well as between 
RSA and somatic symptoms. This indicates that both sympathetic and parasympathetic 
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responses are important in explaining the relationship between perseverative cognition 
and somatic symptoms. Future studies should seek to explore the roles of these 
complementary systems in tandem, taking into account both the reactivity and regulatory 
functions of the autonomic nervous system. 
In conclusion, the present study did not find compelling evidence that 
physiological activation, as indexed by RSA or EDR, was an explanatory factor in the 
relationship between perseverative cognition and somatic symptoms. However, in post 
hoc analyses a pattern emerged which suggested that perseverative cognition is related to 
sympathetic nervous system functioning, whereas parasympathetic nervous system 
functioning was related to reporting of somatic symptoms. Therefore, future research 
could benefit from exploration of the combined impact of sympathetic and 
parasympathetic functioning on the relationship between perseverative cognition and 
somatic symptoms.   
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Participant Demographics          
 N %   N %   N % 
Biological Sex    Age    Ethnicity   
Male 34 15.5  18 103 46.8  Caucasian/White 144 65.5 
Female 186 84.5  19 57 25.9  Asian 32 14.5 
    20 25 11.4  African American 8 3.6 
Gender    21 14 6.4  Hispanic/Latino 20 9.1 
Male 33 15.0  22 6 2.7  Mixed Ethnicity 13 5.9 
Female 183 83.2  23 2 0.9  Other/Missing 3 1.4 
Transgender 4 1.8  24 1 0.5  Race   
    26 1 0.5  Caucasian 157 71.4 
Year in College    27 2 0.9  African American 10 4.5 
Freshman 145 65.9  28 1 0.5  Asian American 29 13.2 
Sophomore 35 15.9  29 1 0.5  Native American 1 0.5 
Junior 25 11.4  39 1 0.5  Pacific Islander 5 2.3 
Senior 9 4.1  Missing 6 2.7  Mixed Race 10 4.5 
Other  6 2.7      Missing 8 3.6 
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Table 2 
Assessing Univariate Normality of Continuous Variables 
Variables Histogram Shapiro-Wilk Test of 
Normality 
Kurtosis Skewness 










0.94*** 219 <0.001 0.08 0.24 0.83*** 5.06 












0.97*** 220 <0.001 -0.81 -2.48 0.09 0.57 






0.97*** 215 <0.001 -0.32 -1.93 -0.78* -2.35 
Stressor Task R Df P kurtosis z kurt skewness z skew 
Basal RSA 
 
0.98 160 0.057 0.88* 2.35 0.04 0.21 









0.98* 160 0.043 0.98 2.60 0.46* 2.43 








0.98* 160 0.035 1.41 3.74 -0.09 -0.49 





0.92 160 <0.001 3.99*** 10.58 -0.30 -1.57 
Somatic Symptoms R Df P kurtosis z kurt skewness z skew 
Day 1 
 
0.93*** 163 <0.001 0.91* 2.42 0.97*** 5.08 




0.92*** 160 <0.001 0.30 0.80 0.93*** 4.84 
Day 3 
 
0.94*** 153 <0.001 -0.09 -0.23 0.73*** 3.72 




0.88*** 153 <0.001 3.63*** 9.31 1.53*** 7.79 
Day 5 
 
0.92*** 157 <0.001 0.84* 2.18 0.94*** 4.84 





Bivariate Correlations and Descriptive Statistics among Variables at Baseline 
Variable N 1 2 3 4 5 6 M (SD) 
1. Gender (0 = male, 1 = female) 220       0.85 (0.36) 
2. Age 214 -0.09      19.63 (2.10) 
3. Trauma History (BTQ) 219 -0.13 0.18**     1.45 (1.76) 
4. Depressive Symptoms (CES-D) 219 0.11 0.03 0.15*    17.13 (10.22) 
5. Anxiety Symptoms (GAD-IV) 216 0.20** -0.00 0.14* 0.57**   6.36 (2.81) 
6. Trait Rumination (RRS-B) 220 0.15* -0.12 0.17* 0.55** 0.44**  12.04 (3.53) 
7. Trait Worry (PSWQ) 215 0.30** -0.15* 0.03 0.50** 0.75** 0.45** 56.84 (13.59) 





0.89*** 146 <0.001 0.54 1.35 1.09*** 5.41 
Note. R is the Shapiro-Wilk Test Statistic.  To facilitate interpretation, z values for kurtosis and skewness are calculated by 
dividing by their respective standard error. An absolute value greater than 1.96 is significant p < .05, above 2.58 is significant at 
p < .01, and above 3.29 is significance at p < .001. * denotes p < .05, ** p < .01, *** p <.001. 
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Table 4 
Bivariate Correlations and Descriptive Statistics among Variables at Lab Visit 
Variable N 1 2 3 4 5 6 7 M (SD) 
1. Gender 220        0.85 (0.36) 
2. Age 214 -0.09       19.63 (2.10) 
3. Basal RSA 166 -0.09 -0.07      6.80 (0.96) 
4. RSA During Stressor 165 -0.09 -0.18* 0.67**     5.94 (0.98) 
5. RSA Recovery 164 -0.05 -0.11 0.82** 0.71**    6.79 (0.91) 
6. Basal EDR 165 -0.11 0.07 -0.09 -0.03 -0.01   1.58 (1.56) 
7. EDR During Stressor 164 -0.09 0.04 0.01 0.10 0.10 0.46**  3.02 (1.44) 
8. EDR Recovery 164 -0.13 -0.04 0.03 0.05 0.10 0.63** 0.56** 1.87 (1.46) 
Note. *p < .05, ** p < .01. 
 
Table 5 
Bivariate Correlations and Descriptive Statistics among Daily Somatic Symptoms 
Variable N 1 2 3 4 5 6 7 M (SD) 
1. Gender 220        0.85 (0.36) 
2. Age 214 -0.09       19.63 (2.09) 
3. Day 1 Somatic Symptoms 163 0.20** 0.08      6.60 (4.68) 
4. Day 2 Somatic Symptoms 160 0.16* 0.05 0.80**     5.58 (4.41) 
5. Day 3 Somatic Symptoms 153 0.20* 0.05 0.70** 0.78**    5.91 (4.52) 
6. Day 4 Somatic Symptoms 153 0.17* 0.06 0.56** 0.74** 0.72**   5.34 (4.67) 
7. Day 5 Somatic Symptoms 157 0.15 0.05 0.72** 0.81** 0.74** 0.77**  5.90 (4.74) 
8. Day 6 Somatic Symptoms 146 0.11 0.10 0.64** 0.74** 0.77** 0.76** 0.85** 5.96 (5.41) 
Note *p < .05, ** p < .01. 
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Table 6 
Confirmatory Factor Analyses  




Single factor, no 
covariation among items 2772.32 2823.23 22.17     (5) 4.43 0.13 0.95 0.05 
 





Single factor, no 
covariations among items 9334.03 9496.04 313.55 (104) 3.02 0.10 0.90 0.06 
Two factors, no 
covariations among items 9287.94 9463.45 259.46 (100) 2.59 0.09 0.92 0.05 
Two factors, PSWQ15 
with PSWQ14 9254.78 9433.67 224.30  (99)   2.27 0.08 0.94 0.04 
Two factors, PSWQ15 
with PSWQ7, PSWQ14 9228.86 9411.12 196.38  (98) 2.00 0.07 0.95 0.04 
Two factors, PSWQ15 
with PSWQ7, PSWQ14 
& PSWQ9 with 




No covariation among 
days 4769.26 4826.22 55.29    (9) 5.81 0.17 0.95 0.03 
Covariation among 
consecutive days 4743.14 4815.93 19.17    (4) 4.79 0.15 0.98 0.02 
Note All CFAs were performed with bootstrap resampling procedures (5000 iterations specified). Statistics indicating best fit (for 
AIC and BIC) or adequate fit (for c2 Ratio, RMSEA, CFI, and SRMR) are bolded. 
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Table 7 
Bootstrap Analysis of Direct and Indirect Effects for Hypothesized RSA Model 
IV         à  Mediator à DV 
Β (standardized path coefficient 
and product) SE 
95% CI Two-tailed 
significance Lower Upper 
Indirect Effects 
PC à bRSA à SS -0.01 X -0.08 = 0.00 0.01 -0.02 0.03 0.967  
PC à sRSA à SS -0.12 X 0.09 = -0.01 0.01 -0.05 0.00 0.343  
PC à rRSA à SS -0.11 X 0.07 = -0.01 0.01 -0.04 0.01 0.486  
Sum of indirect effects     -0.02 0.02 -0.07 0.02 0.407  
Direct Effects 
PC à SS  -0.23 0.07 -0.36 -0.08 0.001 ** 
PC à bRSA -0.01 0.09 -0.19 0.18 0.956  
PC à sRSA -0.12 0.08 -0.27 0.05 0.147  
PC à rRSA -0.11 0.10 -0.29 0.09 0.269  
bRSA à SS -0.08 0.06 -0.21 0.04 0.202  
sRSA à SS 0.09 0.06 -0.02 0.21 0.099 ǂ 
rRSA à SS 0.07 0.06 -0.05 0.19 0.267  
Notes. PC =perseverative cognition, bRSA = basal RSA, sRSA = RSA reactivity during stressor, rRSA = RSA 
recovery, SS = somatic symptoms. ǂ = p<.10, * p < .05, ** p < 0.01 
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Table 8 
Bootstrap Analysis of Direct and Indirect Effects for Hypothesized EDR Model 
IV          à Mediator à DV 
β (standardized path coefficient 
and product) SE 
95% CI Two-tailed 
significance Lower Upper 
Indirect Effects 
PC à bEDR à SS -0.10 X -0.03 = 0.00 0.03 -0.01 0.05 0.926  
PC à sEDR à SS 0.18 X -0.06 = -0.01 0.06 -0.06 0.01 0.846  
PC à rEDR à SS 0.06 X 0.07 = 0.00 0.03 -0.01 0.18 0.876  
Sum of indirect effects     -0.00 0.10 -0.04 0.03 0.972  
Direct Effects 
PC à SS  -0.23 0.13 -0.37 -0.06 0.074 ǂ 
PC à bEDR -0.10 0.12 -0.30 0.11 0.430  
PC à sEDR 0.18 0.13 -0.04 0.40 0.144  
PC à rEDR 0.06 0.12 -0.12 0.26 0.634  
bEDR à SS -0.03 0.08 -0.16 0.11 0.688  
sEDR à SS -0.06 0.10 -0.21 0.10 0.546  
rEDR à SS 0.07 0.08 -0.07 0.23 0.341  
Notes. PC =perseverative cognition, bEDR = EDR at baseline, sEDR = EDR reactivity during stressor, rEDR = 
EDR during recovery period, SS = somatic symptoms. ǂ = p<.10, * p < .05, ** p < 0.01 
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Table 9 
Model Comparison for Total Effect 
Covariates AIC BIC c2 (df) c2 Ratio RMSEA CFI SRMR 
Hypothesized Model 
Sex, BTQ, GAD, CESD 16459.96 16790.28 768.75 (415) 1.85 0.063 0.900 0.218 
Alternative Models 
Sex, BTQ, GAD 16512.68 16840.98 684.29 (389) 1.76 0.059 0.915 0.193 
Sex, BTQ, CESD 16534.68 16862.08 621.03 (389) 1.60 0.052 0.932 0.138 
Sex, BTQ 16600.94 16926.29 468.39 (363) 1.29 0.036 0.968 0.072 
Note All regressions were performed with bootstrap resampling procedures (5000 iterations specified). 
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Table 10 
Bootstrap Analysis of Direct and Indirect Effects for Alternative RSA Model 




Β (standardized path coefficient and 
product) SE 
95% CI Two-tailed 
significance Lower Upper 
Indirect Effects 
PC à bRSA à SS -0.01 X -0.10 = 0.00 0.01 -0.02 0.03 0.961  
PC à sRSA à SS -0.12 X 0.03 = -0.00 0.01 -0.04 0.01 0.786  
PC à rRSA à SS -0.11 X 0.12 = -0.01 0.01 -0.07 0.01 0.433  
Sum of indirect effects     -0.02 0.03 -0.08 0.03 0.580  
Direct Effects 
PC à SS  0.38 0.08 0.22 0.52 <0.001 ** 
PC à bRSA -0.01 0.09 -0.18 0.18 0.945  
PC à sRSA -0.12 0.08 -0.27 0.04 0.144  
PC à rRSA -0.11 0.10 -0.29 0.10 0.265  
bRSA à SS -0.10 0.10 -0.29 0.08 0.275  
sRSA à SS 0.03 0.08 -0.14 0.18 0.711  
rRSA à SS 0.12 0.08 -0.04 0.30 0.173  
Notes. PC =perseverative cognition, bRSA = basal RSA, sRSA = RSA reactivity during stressor, rRSA = RSA 
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Table 11 
Bootstrap Analysis of Direct and Indirect Effects for Alternative EDR Model 
IV          à Mediator à DV 
β (standardized path coefficient 
and product) SE 
95% CI Two-tailed 
significance Lower Upper 
Indirect Effects 
PC à bEDR à SS -0.09 X -0.03 = 0.00 0.03 -0.02 0.05 0.917  
PC à sEDR à SS 0.18 X -0.11 = -0.02 0.06 -0.11 0.01 0.711  
PC à rEDR à SS 0.06 X 0.07 = 0.00 0.02 -0.01 0.05 0.870  
Sum of indirect effects     -0.01 0.10 -0.08 0.02 0.886  
Direct Effects 
PC à SS  0.37 0.13 0.20 0.51 0.003 ** 
PC à bEDR -0.09 0.11 -0.27 0.11 0.389  
PC à sEDR 0.18 0.11 -0.03 0.37 0.098 ǂ 
PC à rEDR 0.06 0.10 -0.13 0.25 0.591  
bEDR à SS -0.03 0.10 -0.23 0.18 0.748  
sEDR à SS -0.11 0.11 -0.31 0.07 0.303  
rEDR à SS 0.07 0.11 -0.11 0.28 0.514  
Notes. PC =perseverative cognition, bEDR = EDR at baseline, sEDR = EDR reactivity during stressor, rEDR = 
EDR during recovery period, SS = somatic symptoms. ǂ = p<.10, * p < .05, ** p < 0.01 
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Table 12 
Bootstrap Analysis of Direct and Indirect Effects for Individual RSA Mediations 
Path 
β (standardized path coefficient 
and product) SE 
95% CI Two-tailed 
significance Lower Upper 
Basal RSA 
PC à SS   0.36 0.07 0.21 0.49 <0.001 ** 
PC à bRSA  -0.02 0.09 -0.17 0.16 0.858  
bRSA à SS  -0.15 0.08 -0.31 0.00 0.064 ǂ 
PC à bRSA à SS -0.02 X -0.15 = 0.00 0.01 -0.02 0.03 0.873  
RSA Reactivity During Stressor 
PC à SS   0.37 0.07 0.21 0.50 <0.001 ** 
PC à sRSA  -0.11 0.07 -0.26 0.03 0.123  
sRSA à SS  0.11 0.07 -0.03 0.24 0.099 ǂ 
PC à sRSA à SS -0.11 X 0.11 = -0.01 0.01 -0.05 0.00 0.373  
RSA During Recovery Period 
PC à SS   0.37 0.07 0.22 0.50 <0.001 ** 
PC à rRSA  -0.10 0.09 -0.28 0.08 0.259  
rRSA à SS  0.16 0.08 0.02 0.31 0.029 * 
PC à rRSA à SS -0.10 X 0.16 = -0.02 0.02 -0.07 0.01 0.336  
Notes. PC =perseverative cognition, bRSA = basal RSA, sRSA = RSA reactivity during stressor, rRSA RSA 
recovery, SS = somatic symptoms. ǂ = p<.10, * p < .05, ** p < 0.01 
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Table 13 
Bootstrap Analysis of Direct and Indirect Effects for Individual EDR Mediations 
Path 
β (standardized path coefficient 




Lower Upper  
Basal EDR 
PC à SS   0.36 0.07 0.20 0.49 <0.001 ** 
PC à bEDR  -0.08 0.08 -0.23 0.08 0.313  
bEDR à SS  -0.01 0.09 -0.17 0.17 0.915  
PC à bEDR à SS -0.08 X -0.01 = 0.00 0.01 -0.02 0.03 0.940  
EDR Reactivity During Stressor 
PC à SS   0.37 0.08 0.21 0.50 <0.001 ** 
PC à sEDR  0.17 0.08 0.00 0.33 0.041 * 
sEDR à SS  -0.05 0.08 -0.21 0.11 0.539  
PC à sEDR à SS 0.17 X -0.05 = -0.01 0.02 -0.06 0.01 0.595  
EDR During Recovery Period 
PC à SS   0.36 0.07 0.21 0.49 <0.001 ** 
PC à rEDR  0.04 0.08 -0.11 0.20 0.602  
rEDR à SS  0.03 0.08 -0.13 0.20 0.729  
PC à rEDR à SS 0.04 X 0.03 = 0.00 0.01 -0.01 0.03 0.869  
Notes. PC =perseverative cognition, bEDR = EDR at baseline, sEDR = EDR reactivity during stressor, rEDR = EDR 
during recovery period, SS = somatic symptoms. ǂ = p<.10, * p < .05, ** p < 0.01 
 
  




Figure 1. Brosschot, Gerin, and Thayer’s (2006) perseverative cognition hypothesis 
(reprinted from Brosschot et al., 2006). 
  




Figure 2. Theoretical model for the present study. Perseverative cognition will predict the 
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Figure 3. Hypothesized measurement models for examination of the mediating 
relationship of physiological activation on the association between perseverative 
cognition and somatic symptoms. 
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Figure 4. Measurement models of latent variables based on confirmatory factor analyses. 
Figure 4a. Measurement model of rumination. 
 
Figure 4b. Measurement model of worry. 
 
Figure 4c. Measurement model of daily somatic symptoms. 
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Figure 5.  Test of hypothesized mediation models including gender, trauma history, 
anxiety, and depression as covariates. 
Figure 5a.  Test of hypothesized RSA mediation model. 
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Figure 6.  Test of mediation models including gender and trauma history covariates. 
 
Figure 6a.  Test of RSA mediation model. 
 
Figure 6b. Test of EDR mediation model. 
 
